Protein cluster,,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count,category,subcategory
0,HALLMARK_COAGULATION,HALLMARK_COAGULATION,HALLMARK_COAGULATION,9/16,138/4383,2.2258905656632773e-10,3.338835848494916e-09,2.577346970768005e-09,C1R/C1S/C3/C8A/C8B/C8G/C9/MASP2/PROS1,9,,
0,HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,4/16,200/4383,0.004966562758346572,0.03724922068759929,0.02875378439042752,C1R/C1S/C3/C9,4,,
0,hsa04610,hsa04610,Complement and coagulation cascades,12/17,88/8843,2.577237185849905e-21,1.1597567336324574e-19,8.138643744789175e-20,C1R/C1S/C3/C5/C7/C8A/C8B/C8G/C9/MASP1/MASP2/PROS1,12,Organismal Systems,Immune system
0,hsa05171,hsa05171,Coronavirus disease - COVID-19,11/17,238/8843,4.581892697941625e-14,1.0309258570368656e-12,7.234567417802565e-13,C1R/C1S/C3/C5/C7/C8A/C8B/C8G/C9/MASP1/MASP2,11,Human Diseases,Infectious disease: viral
0,hsa05322,hsa05322,Systemic lupus erythematosus,9/17,139/8843,9.865710957962004e-13,1.4798566436943007e-11,1.03849589031179e-11,C1R/C1S/C3/C5/C7/C8A/C8B/C8G/C9,9,Human Diseases,Immune disease
0,hsa05150,hsa05150,Staphylococcus aureus infection,6/17,100/8843,2.0119240878836047e-08,2.2634145988690551e-07,1.588361122013372e-07,C1R/C1S/C3/C5/MASP1/MASP2,6,Human Diseases,Infectious disease: bacterial
0,hsa05133,hsa05133,Pertussis,5/17,78/8843,2.671528379113602e-07,2.4043755412022417e-06,1.6872810815454327e-06,C1R/C1S/C3/C5/CD14,5,Human Diseases,Infectious disease: bacterial
0,hsa05146,hsa05146,Amoebiasis,5/17,103/8843,1.0767198304528602e-06,8.07539872839645e-06,5.666946476067686e-06,C8A/C8B/C8G/C9/CD14,5,Human Diseases,Infectious disease: parasitic
0,hsa04810,hsa04810,Regulation of actin cytoskeleton,6/17,230/8843,2.8235302639307523e-06,1.815126598241198e-05,1.2737730513973318e-05,C5/C7/C8A/C8B/C8G/C9,6,Cellular Processes,Cell motility
0,hsa05020,hsa05020,Prion disease,6/17,278/8843,8.45236571793057e-06,4.754455716335946e-05,3.3364601518146986e-05,C5/C7/C8A/C8B/C8G/C9,6,Human Diseases,Neurodegenerative disease
0,hsa04936,hsa04936,Alcoholic liver disease,3/17,144/8843,0.002432310975764509,0.012161554878822546,0.008534424476366698,C3/C5/CD14,3,Human Diseases,Endocrine and metabolic disease
0,hsa04145,hsa04145,Phagosome,3/17,157/8843,0.0031093534316119584,0.013992090442253812,0.009819010836669341,C1R/C3/CD14,3,Cellular Processes,Transport and catabolism
0,hsa05134,hsa05134,Legionellosis,2/17,56/8843,0.005040098523228462,0.0206185848677528,0.014469182363335296,C3/CD14,2,Human Diseases,Infectious disease: bacterial
0,R-HSA-166658,R-HSA-166658,Complement cascade,13/22,58/11009,2.7261731977882843e-25,2.7534349297661674e-23,1.693097038626408e-23,C1R/C1S/C3/C5/C7/C8A/C8B/C8G/C9/CPN2/MASP1/MASP2/PROS1,13,,
0,R-HSA-977606,R-HSA-977606,Regulation of Complement cascade,11/22,47/11009,1.6564219045341186e-21,8.364930617897298e-20,5.1436259140796305e-20,C1R/C1S/C3/C5/C7/C8A/C8B/C8G/C9/CPN2/PROS1,11,,
0,R-HSA-166663,R-HSA-166663,Initial triggering of complement,5/22,23/11009,6.430597901905622e-10,2.164967960308226e-08,1.3312465832015145e-08,C1R/C1S/C3/MASP1/MASP2,5,,
0,R-HSA-166786,R-HSA-166786,Creation of C4 and C2 activators,4/22,14/11009,1.181456933878758e-08,2.983178758043864e-07,1.8343673447064924e-07,C1R/C1S/MASP1/MASP2,4,,
0,R-HSA-3000480,R-HSA-3000480,Scavenging by Class A Receptors,2/22,19/11009,0.0006386147920663322,0.01290001879973991,0.007932267943560759,APOB/MASP1,2,,
0,R-HSA-5686938,R-HSA-5686938,Regulation of TLR by endogenous ligand,2/22,21/11009,0.000782367688140833,0.013169856083704022,0.00809819185970336,APOB/CD14,2,,
0,R-HSA-8957275,R-HSA-8957275,Post-translational protein phosphorylation,3/22,108/11009,0.0012344572540130654,0.01781145466504566,0.010952327516807647,APOB/C3/SERPINA10,3,,
0,R-HSA-381426,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),3/22,125/11009,0.0018795411233203173,0.023080820314685033,0.014192479401421751,APOB/C3/SERPINA10,3,,
0,R-HSA-114608,R-HSA-114608,Platelet degranulation,3/22,129/11009,0.002056706760714508,0.023080820314685033,0.014192479401421751,ITIH3/ITIH4/PROS1,3,,
0,R-HSA-76005,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,3/22,134/11009,0.002292408626915127,0.023153327131842785,0.01423706410399921,ITIH3/ITIH4/PROS1,3,,
0,R-HSA-2173782,R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,2/22,42/11009,0.003127285066950192,0.028714162887451763,0.017656442004790555,APOB/MASP1,2,,
0,R-HSA-418990,R-HSA-418990,Adherens junctions interactions,2/22,57/11009,0.005692890731976453,0.04791516366080181,0.02946320641987813,CDH1/CDH5,2,,
0,GO:0006956,GO:0006956,complement activation,11/23,67/18870,6.232322693613184e-22,2.7260301526017845e-19,2.0528000339430443e-19,C1R/C1S/C3/C5/C7/C8A/C8B/C8G/C9/MASP1/MASP2,11,,
0,GO:0006958,GO:0006958,"complement activation, classical pathway",10/23,42/18870,1.048473135616071e-21,2.7260301526017845e-19,2.0528000339430443e-19,C1R/C1S/C3/C5/C7/C8A/C8B/C8G/C9/MASP2,10,,
0,GO:0002455,GO:0002455,humoral immune response mediated by circulating immunoglobulin,10/23,55/18870,2.0671638910963216e-20,3.583084077900291e-18,2.698192868378357e-18,C1R/C1S/C3/C5/C7/C8A/C8B/C8G/C9/MASP2,10,,
0,GO:0006957,GO:0006957,"complement activation, alternative pathway",7/23,18/18870,4.583129103366254e-17,5.95806783437613e-15,4.486642174874332e-15,C3/C5/C7/C8A/C8B/C8G/C9,7,,
0,GO:0006959,GO:0006959,humoral immune response,11/23,258/18870,2.949817221582357e-15,3.0678099104456515e-13,2.31017264511292e-13,C1R/C1S/C3/C5/C7/C8A/C8B/C8G/C9/MASP1/MASP2,11,,
0,GO:0016064,GO:0016064,immunoglobulin mediated immune response,10/23,205/18870,1.8584785227507505e-14,1.5986470649728895e-12,1.2038394902224997e-12,C1R/C1S/C3/C5/C7/C8A/C8B/C8G/C9/MASP2,10,,
0,GO:0019724,GO:0019724,B cell mediated immunity,10/23,208/18870,2.1520248951558127e-14,1.5986470649728895e-12,1.2038394902224997e-12,C1R/C1S/C3/C5/C7/C8A/C8B/C8G/C9/MASP2,10,,
0,GO:0002449,GO:0002449,lymphocyte mediated immunity,10/23,368/18870,6.433670215008511e-12,4.181885639755532e-10,3.149112263135745e-10,C1R/C1S/C3/C5/C7/C8A/C8B/C8G/C9/MASP2,10,,
0,GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,10/23,380/18870,8.834942436900243e-12,5.104633407986807e-10,3.8439749550022113e-10,C1R/C1S/C3/C5/C7/C8A/C8B/C8G/C9/MASP2,10,,
0,GO:0002443,GO:0002443,leukocyte mediated immunity,10/23,466/18870,6.577003158656223e-11,3.420041642501236e-09,2.5754159737053843e-09,C1R/C1S/C3/C5/C7/C8A/C8B/C8G/C9/MASP2,10,,
0,GO:0031640,GO:0031640,killing of cells of another organism,6/23,92/18870,1.0749106161501472e-09,4.657946003317305e-08,3.507603063226796e-08,C5/C7/C8A/C8B/C8G/C9,6,,
0,GO:0141061,GO:0141061,disruption of cell in another organism,6/23,92/18870,1.0749106161501472e-09,4.657946003317305e-08,3.507603063226796e-08,C5/C7/C8A/C8B/C8G/C9,6,,
0,GO:0141060,GO:0141060,disruption of anatomical structure in another organism,6/23,99/18870,1.6799984533117893e-09,6.719993813247158e-08,5.0604001994492765e-08,C5/C7/C8A/C8B/C8G/C9,6,,
0,GO:0001906,GO:0001906,cell killing,7/23,223/18870,6.115664255489689e-09,2.2715324377533132e-07,1.7105466940166647e-07,C3/C5/C7/C8A/C8B/C8G/C9,7,,
0,GO:0001867,GO:0001867,"complement activation, lectin pathway",2/23,11/18870,7.764111349832982e-05,0.0026915586012754337,0.002026841699745873,MASP1/MASP2,2,,
0,GO:0010884,GO:0010884,positive regulation of lipid storage,2/23,27/18870,0.0004896467589538269,0.015913519665999375,0.011983460153343659,APOB/C3,2,,
0,GO:0010575,GO:0010575,positive regulation of vascular endothelial growth factor production,2/23,30/18870,0.0006054792638679335,0.018520542188901496,0.013946643105812463,C3/C5,2,,
0,GO:0030212,GO:0030212,hyaluronan metabolic process,2/23,34/18870,0.0007785481094292778,0.022491389827956915,0.01693683606477727,ITIH3/ITIH4,2,,
0,GO:0016339,GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,2/23,47/18870,0.0014858196047839102,0.038927515810804426,0.02931383781704301,CDH1/CDH5,2,,
0,GO:0044331,GO:0044331,cell-cell adhesion mediated by cadherin,2/23,48/18870,0.0015492728297867209,0.038927515810804426,0.02931383781704301,CDH1/CDH5,2,,
0,GO:0042060,GO:0042060,wound healing,4/23,423/18870,0.001572072753897871,0.038927515810804426,0.02931383781704301,ANXA6/FBLN1/PROS1/SERPINA10,4,,
0,GO:0010883,GO:0010883,regulation of lipid storage,2/23,54/18870,0.001956722747468449,0.04624981039470879,0.03482779244297909,APOB/C3,2,,
0,GO:0034332,GO:0034332,adherens junction organization,2/23,57/18870,0.002177500241794803,0.047984833253003636,0.03613432787473149,CDH1/CDH5,2,,
0,GO:0010574,GO:0010574,regulation of vascular endothelial growth factor production,2/23,59/18870,0.0023309477164699887,0.047984833253003636,0.03613432787473149,C3/C5,2,,
0,GO:0031638,GO:0031638,zymogen activation,2/23,59/18870,0.0023309477164699887,0.047984833253003636,0.03613432787473149,C1R/MASP1,2,,
0,GO:0007596,GO:0007596,blood coagulation,3/23,224/18870,0.0024526767562285975,0.047984833253003636,0.03613432787473149,FBLN1/PROS1/SERPINA10,3,,
0,GO:0050817,GO:0050817,coagulation,3/23,229/18870,0.0026110091690385077,0.047984833253003636,0.03613432787473149,FBLN1/PROS1/SERPINA10,3,,
0,GO:0010573,GO:0010573,vascular endothelial growth factor production,2/23,63/18870,0.002652768631729806,0.047984833253003636,0.03613432787473149,C3/C5,2,,
0,GO:0007599,GO:0007599,hemostasis,3/23,231/18870,0.0026760772391098185,0.047984833253003636,0.03613432787473149,FBLN1/PROS1/SERPINA10,3,,
1,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,6/17,200/4383,6.797092862870337e-05,0.0010875348580592539,0.0008585801510994109,COL6A3/COMP/LRP1/PCOLCE/PVR/QSOX1,6,,
1,HALLMARK_MYOGENESIS,HALLMARK_MYOGENESIS,HALLMARK_MYOGENESIS,5/17,200/4383,0.0007428007122570968,0.005942405698056774,0.004691372919518506,APOD/CDH13/COL6A3/IGF1/SOD3,5,,
1,HALLMARK_COAGULATION,HALLMARK_COAGULATION,HALLMARK_COAGULATION,4/17,138/4383,0.00162695002618438,0.008677066806316693,0.006850315899723705,COMP/CPB2/LRP1/PROZ,4,,
1,R-HSA-381426,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),5/23,125/11009,4.974600728046207e-06,0.00035206279681629214,0.0002846935129361443,AHSG/IGF1/KNG1/PCSK9/QSOX1,5,,
1,R-HSA-114608,R-HSA-114608,Platelet degranulation,5/23,129/11009,5.806034328148063e-06,0.00035206279681629214,0.0002846935129361443,AHSG/CD109/IGF1/KNG1/QSOX1,5,,
1,R-HSA-76005,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,5/23,134/11009,6.994625102310439e-06,0.00035206279681629214,0.0002846935129361443,AHSG/CD109/IGF1/KNG1/QSOX1,5,,
1,R-HSA-8957275,R-HSA-8957275,Post-translational protein phosphorylation,4/23,108/11009,6.718225963960766e-05,0.0025361303013951893,0.002050826873209076,AHSG/KNG1/PCSK9/QSOX1,4,,
1,R-HSA-76002,R-HSA-76002,"Platelet activation, signaling and aggregation",5/23,263/11009,0.00017709973041903318,0.005348411858654802,0.004324961837601653,AHSG/CD109/IGF1/KNG1/QSOX1,5,,
1,GO:0042060,GO:0042060,wound healing,6/28,423/18870,3.035765024506645e-05,0.010252672362773814,0.0073668610113200505,CD109/COMP/CPB2/IGF1/KNG1/PROZ,6,,
1,GO:0003018,GO:0003018,vascular process in circulatory system,5/28,269/18870,4.2616348488947646e-05,0.010252672362773814,0.0073668610113200505,COMP/DBH/KNG1/LRP1/SOD3,5,,
1,GO:1900047,GO:1900047,negative regulation of hemostasis,3/28,49/18870,5.149674146507215e-05,0.010252672362773814,0.0073668610113200505,COMP/CPB2/KNG1,3,,
1,GO:0035296,GO:0035296,regulation of tube diameter,4/28,146/18870,6.093906170923552e-05,0.010252672362773814,0.0073668610113200505,COMP/DBH/KNG1/SOD3,4,,
1,GO:0097746,GO:0097746,blood vessel diameter maintenance,4/28,146/18870,6.093906170923552e-05,0.010252672362773814,0.0073668610113200505,COMP/DBH/KNG1/SOD3,4,,
1,GO:0035150,GO:0035150,regulation of tube size,4/28,147/18870,6.257989234653396e-05,0.010252672362773814,0.0073668610113200505,COMP/DBH/KNG1/SOD3,4,,
1,GO:0048660,GO:0048660,regulation of smooth muscle cell proliferation,4/28,171/18870,0.00011247636096969155,0.0151104240962604,0.010857305315190587,APOD/CDH13/DBH/IGF1,4,,
1,GO:0048659,GO:0048659,smooth muscle cell proliferation,4/28,175/18870,0.00012297394991870112,0.0151104240962604,0.010857305315190587,APOD/CDH13/DBH/IGF1,4,,
1,GO:1900046,GO:1900046,regulation of hemostasis,3/28,70/18870,0.00014984594545643259,0.016116105277075028,0.011579918231961604,COMP/CPB2/KNG1,3,,
1,GO:0010642,GO:0010642,negative regulation of platelet-derived growth factor receptor signaling pathway,2/28,13/18870,0.00016394817168947128,0.016116105277075028,0.011579918231961604,APOD/LRP1,2,,
1,GO:0061045,GO:0061045,negative regulation of wound healing,3/28,75/18870,0.00018392866164025835,0.016436534035670358,0.011810156168479748,CD109/CPB2/KNG1,3,,
1,GO:0050678,GO:0050678,regulation of epithelial cell proliferation,5/28,407/18870,0.0002972280146779333,0.021458569955507868,0.015418643722381302,CD109/CDH13/CPB2/DBH/IGF1,5,,
1,GO:0007178,GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,5/28,410/18870,0.0003074563701197221,0.021458569955507868,0.015418643722381302,CD109/COMP/LRP1/VASN/WIF1,5,,
1,GO:0007596,GO:0007596,blood coagulation,4/28,224/18870,0.00031643190936638514,0.021458569955507868,0.015418643722381302,COMP/CPB2/KNG1/PROZ,4,,
1,GO:0050817,GO:0050817,coagulation,4/28,229/18870,0.0003440929063349418,0.021458569955507868,0.015418643722381302,COMP/CPB2/KNG1/PROZ,4,,
1,GO:0007599,GO:0007599,hemostasis,4/28,231/18870,0.00035562871879072624,0.021458569955507868,0.015418643722381302,COMP/CPB2/KNG1/PROZ,4,,
1,GO:0045861,GO:0045861,negative regulation of proteolysis,4/28,235/18870,0.00037952945552703686,0.021458569955507868,0.015418643722381302,AHSG/CPB2/KNG1/LRP1,4,,
1,GO:1903035,GO:1903035,negative regulation of response to wounding,3/28,97/18870,0.00039293413957186324,0.021458569955507868,0.015418643722381302,CD109/CPB2/KNG1,3,,
1,GO:0033002,GO:0033002,muscle cell proliferation,4/28,247/18870,0.0004581413176450817,0.023702785012900806,0.017031181392789464,APOD/CDH13/DBH/IGF1,4,,
1,GO:0010640,GO:0010640,regulation of platelet-derived growth factor receptor signaling pathway,2/28,24/18870,0.0005742958456076557,0.028226640811616275,0.020281711179091423,APOD/LRP1,2,,
1,GO:0050673,GO:0050673,epithelial cell proliferation,5/28,480/18870,0.00063172583989186,0.029570785743509447,0.021247520730197398,CD109/CDH13/CPB2/DBH/IGF1,5,,
1,GO:0030282,GO:0030282,bone mineralization,3/28,123/18870,0.0007859709916289081,0.03511861294414621,0.025233805520717575,AHSG/COMP/IGF1,3,,
1,GO:0030100,GO:0030100,regulation of endocytosis,4/28,291/18870,0.0008471051851205275,0.03613519035929396,0.025964247717605873,AHSG/CDH13/LRP1/PCSK9,4,,
1,GO:0030301,GO:0030301,cholesterol transport,3/28,128/18870,0.0008822426944283367,0.03613519035929396,0.025964247717605873,APOM/LRP1/PCSK9,3,,
1,GO:0061041,GO:0061041,regulation of wound healing,3/28,133/18870,0.0009857087810230228,0.03875806926982526,0.027848867034376775,CD109/CPB2/KNG1,3,,
1,GO:0042157,GO:0042157,lipoprotein metabolic process,3/28,135/18870,0.0010291560149428202,0.03891001394956893,0.027958043968689575,APOD/APOM/PCSK9,3,,
1,GO:0010466,GO:0010466,negative regulation of peptidase activity,3/28,137/18870,0.0010738003747330278,0.03909428771713208,0.02809045034876654,AHSG/KNG1/LRP1,3,,
1,GO:0015918,GO:0015918,sterol transport,3/28,141/18870,0.0011667316903425672,0.039546977790578426,0.028415722115412673,APOM/LRP1/PCSK9,3,,
1,GO:0030198,GO:0030198,extracellular matrix organization,4/28,321/18870,0.001218891616457349,0.039546977790578426,0.028415722115412673,COMP/CPB2/LRP1/QSOX1,4,,
1,GO:0043062,GO:0043062,extracellular structure organization,4/28,322/18870,0.001232967810481157,0.039546977790578426,0.028415722115412673,COMP/CPB2/LRP1/QSOX1,4,,
1,GO:0045229,GO:0045229,external encapsulating structure organization,4/28,323/18870,0.0012471579974648334,0.039546977790578426,0.028415722115412673,COMP/CPB2/LRP1/QSOX1,4,,
1,GO:0045807,GO:0045807,positive regulation of endocytosis,3/28,155/18870,0.0015315457603436186,0.04704717132555553,0.03380484227600553,AHSG/LRP1/PCSK9,3,,
2,HALLMARK_COAGULATION,HALLMARK_COAGULATION,HALLMARK_COAGULATION,11/18,138/4383,5.341802743153298e-13,6.944343566099288e-12,5.060655230355756e-12,APOC1/APOC2/APOC3/CLU/CPN1/F2/F9/FN1/GSN/ITIH1/PROC,11,,
2,HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,6/18,200/4383,9.811105868081877e-05,0.000637721881425322,0.0004647365937512468,APOC1/CLU/F2/F7/FN1/ITIH1,6,,
2,HALLMARK_XENOBIOTIC_METABOLISM,HALLMARK_XENOBIOTIC_METABOLISM,HALLMARK_XENOBIOTIC_METABOLISM,4/18,200/4383,0.007773445728915644,0.03368493149196779,0.024547723354470457,APOE/FETUB/ITIH1/LCAT,4,,
2,hsa04610,hsa04610,Complement and coagulation cascades,8/22,88/8843,1.9854374625783543e-11,7.346118611539911e-10,6.896782764745862e-10,CLU/F2/F7/F9/PROC/SERPINA5/SERPIND1/SERPINF2,8,Organismal Systems,Immune system
2,hsa04979,hsa04979,Cholesterol metabolism,5/22,51/8843,1.2764398601787753e-07,2.3614137413307343e-06,2.216974493994715e-06,APOC1/APOC2/APOC3/APOE/LCAT,5,Organismal Systems,Digestive system
2,R-HSA-140877,R-HSA-140877,Formation of Fibrin Clot (Clotting Cascade),6/28,39/11009,4.703764081764845e-10,2.8907715332721922e-08,1.592554902737263e-08,F2/F7/F9/PROC/SERPINA5/SERPIND1,6,,
2,R-HSA-174824,R-HSA-174824,"Plasma lipoprotein assembly, remodeling, and clearance",7/28,75/11009,5.403311277144284e-10,2.8907715332721922e-08,1.592554902737263e-08,APOC1/APOC2/APOC3/APOC4/APOE/APOF/LCAT,7,,
2,R-HSA-8963898,R-HSA-8963898,Plasma lipoprotein assembly,5/28,19/11009,8.28333338836823e-10,2.954388908518002e-08,1.6276023499951612e-08,APOC1/APOC2/APOC3/APOC4/APOE,5,,
2,R-HSA-140837,R-HSA-140837,Intrinsic Pathway of Fibrin Clot Formation,5/28,23/11009,2.380359396953779e-09,6.367461386851359e-08,3.507898058668727e-08,F2/F9/PROC/SERPINA5/SERPIND1,5,,
2,R-HSA-159740,R-HSA-159740,Gamma-carboxylation of protein precursors,4/28,10/11009,6.955838589488997e-09,1.0632496129647467e-07,5.857548285885471e-08,F2/F7/F9/PROC,4,,
2,R-HSA-159782,R-HSA-159782,Removal of aminoterminal propeptides from gamma-carboxylated proteins,4/28,10/11009,6.955838589488997e-09,1.0632496129647467e-07,5.857548285885471e-08,F2/F7/F9/PROC,4,,
2,R-HSA-8964058,R-HSA-8964058,HDL remodeling,4/28,10/11009,6.955838589488997e-09,1.0632496129647467e-07,5.857548285885471e-08,APOC2/APOC3/APOE/LCAT,4,,
2,R-HSA-159854,R-HSA-159854,"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",4/28,11/11009,1.091153297800354e-08,1.4594175358079736e-07,8.040076931160504e-08,F2/F7/F9/PROC,4,,
2,R-HSA-8963899,R-HSA-8963899,Plasma lipoprotein remodeling,5/28,34/11009,1.9309960494789144e-08,2.1356090708498316e-07,1.1765283617077282e-07,APOC2/APOC3/APOE/APOF/LCAT,5,,
2,R-HSA-381426,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),7/28,125/11009,1.995896327897039e-08,2.1356090708498316e-07,1.1765283617077282e-07,APOE/APOL1/F2/FN1/ITIH2/PROC/SERPIND1,7,,
2,R-HSA-140875,R-HSA-140875,Common Pathway of Fibrin Clot Formation,4/28,22/11009,2.372706136615891e-07,2.1846004868054115e-06,1.2035182219488742e-06,F2/PROC/SERPINA5/SERPIND1,4,,
2,R-HSA-8957275,R-HSA-8957275,Post-translational protein phosphorylation,6/28,108/11009,2.4500192375387793e-07,2.1846004868054115e-06,1.2035182219488742e-06,APOE/APOL1/FN1/ITIH2/PROC/SERPIND1,6,,
2,R-HSA-8963888,R-HSA-8963888,Chylomicron assembly,3/28,10/11009,1.7473031417603432e-06,1.3354388297739766e-05,7.357065860043551e-06,APOC2/APOC3/APOE,3,,
2,R-HSA-8963901,R-HSA-8963901,Chylomicron remodeling,3/28,10/11009,1.7473031417603432e-06,1.3354388297739766e-05,7.357065860043551e-06,APOC2/APOC3/APOE,3,,
2,R-HSA-9029569,R-HSA-9029569,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,4/28,37/11009,2.0868610121611805e-06,1.4886275220083088e-05,8.200997661826395e-06,APOC1/APOC2/APOC4/APOE,4,,
2,R-HSA-9024446,R-HSA-9024446,NR1H2 and NR1H3-mediated signaling,4/28,47/11009,5.538332758098788e-06,3.703760031978565e-05,2.0404383845627114e-05,APOC1/APOC2/APOC4/APOE,4,,
2,R-HSA-166658,R-HSA-166658,Complement cascade,4/28,58/11009,1.2923169907435496e-05,8.13399517703293e-05,4.481099162949769e-05,CLU/COLEC11/CPN1/F2,4,,
2,R-HSA-163841,R-HSA-163841,"Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation",4/28,61/11009,1.5812527487311043e-05,9.39966911745712e-05,5.178371574791921e-05,F2/F7/F9/PROC,4,,
2,R-HSA-8964043,R-HSA-8964043,Plasma lipoprotein clearance,3/28,37/11009,0.00010805161315703829,0.0006085011898843735,0.0003352293815398418,APOC1/APOC4/APOE,3,,
2,R-HSA-2173782,R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,3/28,42/11009,0.00015829065341965368,0.0008468549957951472,0.0004665408732368741,APOE/APOL1/COLEC11,3,,
2,R-HSA-975634,R-HSA-975634,Retinoid metabolism and transport,3/28,44/11009,0.0001819927311347028,0.0009272962967339618,0.000510856789150043,APOC2/APOC3/APOE,3,,
2,R-HSA-977606,R-HSA-977606,Regulation of Complement cascade,3/28,47/11009,0.00022168397409876375,0.0010781902376621692,0.0005939857679201325,CLU/CPN1/F2,3,,
2,R-HSA-6806667,R-HSA-6806667,Metabolism of fat-soluble vitamins,3/28,48/11009,0.00023606082065561428,0.0010981959917456838,0.0006050071376070663,APOC2/APOC3/APOE,3,,
2,R-HSA-114608,R-HSA-114608,Platelet degranulation,4/28,129/11009,0.00029623895558428286,0.0013207320103132611,0.0007276044523122738,CLU/FN1/SERPINA4/SERPINF2,4,,
2,R-HSA-76005,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,4/28,134/11009,0.000342513806867787,0.0014659590933941286,0.0008076115025093084,CLU/FN1/SERPINA4/SERPINF2,4,,
2,R-HSA-76002,R-HSA-76002,"Platelet activation, signaling and aggregation",5/28,263/11009,0.0004691486310369718,0.001930727058498307,0.001063656815306495,CLU/F2/FN1/SERPINA4/SERPINF2,5,,
2,R-HSA-9651496,R-HSA-9651496,Defects of contact activation system (CAS) and kallikrein/kinin system (KKS),2/28,16/11009,0.0007322722385664507,0.002798326054521794,0.0015416257654030543,F2/F9,2,,
2,R-HSA-9671793,R-HSA-9671793,Diseases of hemostasis,2/28,16/11009,0.0007322722385664507,0.002798326054521794,0.0015416257654030543,F2/F9,2,,
2,R-HSA-3000480,R-HSA-3000480,Scavenging by Class A Receptors,2/28,19/11009,0.0010385755581462943,0.0038319856800570168,0.0021110791744534474,APOE/COLEC11,2,,
2,R-HSA-6803157,R-HSA-6803157,Antimicrobial peptides,3/28,95/11009,0.001744059625524663,0.0062204793310379645,0.003426924176469513,CAMP/CLU/PGLYRP2,3,,
2,R-HSA-2187338,R-HSA-2187338,Visual phototransduction,3/28,104/11009,0.0022597569995402257,0.007799806417767876,0.004296991238514521,APOC2/APOC3/APOE,3,,
2,R-HSA-76009,R-HSA-76009,Platelet Aggregation (Plug Formation),2/28,39/11009,0.004361327348063005,0.014583188320085674,0.008034024062221326,F2/FN1,2,,
2,R-HSA-202733,R-HSA-202733,Cell surface interactions at the vascular wall,3/28,137/11009,0.004919011804916921,0.015949523125033654,0.008786751549452874,F2/FN1/PROC,3,,
2,R-HSA-9006931,R-HSA-9006931,Signaling by Nuclear Receptors,4/28,298/11009,0.006451361941177641,0.02030281552076493,0.011185023798945756,APOC1/APOC2/APOC4/APOE,4,,
2,R-HSA-2142753,R-HSA-2142753,Arachidonic acid metabolism,2/28,59/11009,0.009759902762891789,0.029837417017983467,0.01643773096908091,PON1/PON3,2,,
2,R-HSA-196854,R-HSA-196854,Metabolism of vitamins and cofactors,3/28,194/11009,0.01276614382185231,0.03794381635939437,0.020903627310635362,APOC2/APOC3/APOE,3,,
2,R-HSA-3000178,R-HSA-3000178,ECM proteoglycans,2/28,76/11009,0.01583088827436755,0.04578121744208995,0.025221329825450434,COL6A1/FN1,2,,
2,GO:0006869,GO:0006869,lipid transport,11/33,453/18870,1.6263345241694206e-10,9.461649000873529e-08,6.210459265546147e-08,APOC1/APOC2/APOC3/APOC4/APOE/APOF/APOL1/CLU/LCAT/PON1/SERPINA5,11,,
2,GO:0043691,GO:0043691,reverse cholesterol transport,5/33,20/18870,1.812576436948952e-10,9.461649000873529e-08,6.210459265546147e-08,APOC2/APOC3/APOE/CLU/LCAT,5,,
2,GO:0030301,GO:0030301,cholesterol transport,7/33,128/18870,2.066211694702332e-09,4.7168157104535235e-07,3.0960345104912727e-07,APOC1/APOC2/APOC3/APOE/CLU/LCAT/PON1,7,,
2,GO:0034368,GO:0034368,protein-lipid complex remodeling,5/33,33/18870,2.7304065794512905e-09,4.7168157104535235e-07,3.0960345104912727e-07,APOC1/APOC2/APOC3/APOE/LCAT,5,,
2,GO:0034369,GO:0034369,plasma lipoprotein particle remodeling,5/33,33/18870,2.7304065794512905e-09,4.7168157104535235e-07,3.0960345104912727e-07,APOC1/APOC2/APOC3/APOE/LCAT,5,,
2,GO:0034367,GO:0034367,protein-containing complex remodeling,5/33,35/18870,3.72545860093989e-09,4.7168157104535235e-07,3.0960345104912727e-07,APOC1/APOC2/APOC3/APOE/LCAT,5,,
2,GO:0034370,GO:0034370,triglyceride-rich lipoprotein particle remodeling,4/33,12/18870,3.797760198525996e-09,4.7168157104535235e-07,3.0960345104912727e-07,APOC2/APOC3/APOE/LCAT,4,,
2,GO:0034372,GO:0034372,very-low-density lipoprotein particle remodeling,4/33,12/18870,3.797760198525996e-09,4.7168157104535235e-07,3.0960345104912727e-07,APOC2/APOC3/APOE/LCAT,4,,
2,GO:0015918,GO:0015918,sterol transport,7/33,141/18870,4.066220440046141e-09,4.7168157104535235e-07,3.0960345104912727e-07,APOC1/APOC2/APOC3/APOE/CLU/LCAT/PON1,7,,
2,GO:0033700,GO:0033700,phospholipid efflux,4/33,14/18870,7.66103946613963e-09,7.998125202649775e-07,5.249828097323053e-07,APOC1/APOC2/APOC3/APOE,4,,
2,GO:0097006,GO:0097006,regulation of plasma lipoprotein particle levels,6/33,91/18870,1.0614590013599424e-08,1.0074210885634363e-06,6.612534065888254e-07,APOC1/APOC2/APOC3/APOE/GPLD1/LCAT,6,,
2,GO:0034375,GO:0034375,high-density lipoprotein particle remodeling,4/33,16/18870,1.389492824065308e-08,1.2088587569368179e-06,7.934735337425575e-07,APOC1/APOC3/APOE/LCAT,4,,
2,GO:0034384,GO:0034384,high-density lipoprotein particle clearance,4/33,18/18870,2.330438576036679e-08,1.779825059060645e-06,1.1682457284215367e-06,APOC2/APOC3/APOE/GPLD1,4,,
2,GO:0071827,GO:0071827,plasma lipoprotein particle organization,5/33,50/18870,2.386738584947225e-08,1.779825059060645e-06,1.1682457284215367e-06,APOC1/APOC2/APOC3/APOE/LCAT,5,,
2,GO:0071825,GO:0071825,protein-lipid complex organization,5/33,53/18870,3.2206543172928885e-08,2.2415754048358504e-06,1.4713304986369615e-06,APOC1/APOC2/APOC3/APOE/LCAT,5,,
2,GO:0034381,GO:0034381,plasma lipoprotein particle clearance,5/33,55/18870,3.894565244782999e-08,2.541203822220907e-06,1.6680012989169295e-06,APOC1/APOC2/APOC3/APOE/GPLD1,5,,
2,GO:0051346,GO:0051346,negative regulation of hydrolase activity,7/33,218/18870,8.255568247703581e-08,5.069890147413258e-06,3.3277863339040446e-06,APOC1/APOC3/FETUB/SERPINA4/SERPINA5/SERPIND1/SERPINF2,7,,
2,GO:0007596,GO:0007596,blood coagulation,7/33,224/18870,9.937282701082513e-08,5.763623966627857e-06,3.783140958131413e-06,APOE/F2/F7/F9/PROC/SERPIND1/SERPINF2,7,,
2,GO:0030193,GO:0030193,regulation of blood coagulation,5/33,68/18870,1.1483728701957519e-07,6.030043911572555e-06,3.958014303724272e-06,APOE/F2/F7/PROC/SERPINF2,5,,
2,GO:0050817,GO:0050817,coagulation,7/33,229/18870,1.1551808259717538e-07,6.030043911572555e-06,3.958014303724272e-06,APOE/F2/F7/F9/PROC/SERPIND1/SERPINF2,7,,
2,GO:0007599,GO:0007599,hemostasis,7/33,231/18870,1.225694664509254e-07,6.0371746837501215e-06,3.962694816617594e-06,APOE/F2/F7/F9/PROC/SERPIND1/SERPINF2,7,,
2,GO:0034377,GO:0034377,plasma lipoprotein particle assembly,4/33,27/18870,1.3218569689824194e-07,6.0371746837501215e-06,3.962694816617594e-06,APOC1/APOC3/APOE/LCAT,4,,
2,GO:1900046,GO:1900046,regulation of hemostasis,5/33,70/18870,1.3300289054238774e-07,6.0371746837501215e-06,3.962694816617594e-06,APOE/F2/F7/PROC/SERPINF2,5,,
2,GO:0008203,GO:0008203,cholesterol metabolic process,6/33,140/18870,1.4065743717177403e-07,6.1185985169721705e-06,4.016139982404601e-06,APOC1/APOE/APOF/APOL1/LCAT/PON1,6,,
2,GO:0033344,GO:0033344,cholesterol efflux,5/33,73/18870,1.644499061824811e-07,6.603296232865779e-06,4.334287001003854e-06,APOC1/APOC2/APOC3/APOE/PON1,5,,
2,GO:0050818,GO:0050818,regulation of coagulation,5/33,73/18870,1.644499061824811e-07,6.603296232865779e-06,4.334287001003854e-06,APOE/F2/F7/PROC/SERPINF2,5,,
2,GO:0065005,GO:0065005,protein-lipid complex assembly,4/33,30/18870,2.056526263474857e-07,7.894437193476074e-06,5.18176911973475e-06,APOC1/APOC3/APOE/LCAT,4,,
2,GO:1902652,GO:1902652,secondary alcohol metabolic process,6/33,150/18870,2.117282005913123e-07,7.894437193476074e-06,5.18176911973475e-06,APOC1/APOE/APOF/APOL1/LCAT/PON1,6,,
2,GO:0016125,GO:0016125,sterol metabolic process,6/33,154/18870,2.4738461484898657e-07,8.787444254594323e-06,5.76792317981539e-06,APOC1/APOE/APOF/APOL1/LCAT/PON1,6,,
2,GO:0032371,GO:0032371,regulation of sterol transport,5/33,80/18870,2.609298581345057e-07,8.787444254594323e-06,5.76792317981539e-06,APOC1/APOC2/APOC3/APOE/PON1,5,,
2,GO:0032374,GO:0032374,regulation of cholesterol transport,5/33,80/18870,2.609298581345057e-07,8.787444254594323e-06,5.76792317981539e-06,APOC1/APOC2/APOC3/APOE/PON1,5,,
2,GO:0010984,GO:0010984,regulation of lipoprotein particle clearance,4/33,36/18870,4.387841630232858e-07,1.43153333186347e-05,9.396331912110497e-06,APOC1/APOC2/APOC3/GPLD1,4,,
2,GO:0042060,GO:0042060,wound healing,8/33,423/18870,5.068625817431536e-07,1.6035288949692496e-05,1.0525280405575536e-05,APOE/F2/F7/F9/FN1/PROC/SERPIND1/SERPINF2,8,,
2,GO:1905952,GO:1905952,regulation of lipid localization,6/33,183/18870,6.82806728194611e-07,2.096618306574041e-05,1.3761832199835659e-05,APOC1/APOC2/APOC3/APOC4/APOE/PON1,6,,
2,GO:1990000,GO:1990000,amyloid fibril formation,4/33,42/18870,8.276367527223472e-07,2.468722199548944e-05,1.620425642172175e-05,APOE/CAMP/CLU/GSN,4,,
2,GO:0015850,GO:0015850,organic hydroxy compound transport,7/33,308/18870,8.557435732965535e-07,2.4816563625600054e-05,1.6289153982925626e-05,APOC1/APOC2/APOC3/APOE/CLU/LCAT/PON1,7,,
2,GO:0055090,GO:0055090,acylglycerol homeostasis,4/33,43/18870,9.114007426336444e-07,2.5039536192355915e-05,1.6435509236966832e-05,APOC2/APOC3/APOC4/APOE,4,,
2,GO:0070328,GO:0070328,triglyceride homeostasis,4/33,43/18870,9.114007426336444e-07,2.5039536192355915e-05,1.6435509236966832e-05,APOC2/APOC3/APOC4/APOE,4,,
2,GO:0090207,GO:0090207,regulation of triglyceride metabolic process,4/33,44/18870,1.0013083297972398e-06,2.6804253751495344e-05,1.7593838669311826e-05,APOC2/APOC3/APOE/GPLD1,4,,
2,GO:0006641,GO:0006641,triglyceride metabolic process,5/33,106/18870,1.0650923600841299e-06,2.7798910598195792e-05,1.8246713853020225e-05,APOC1/APOC2/APOC3/APOE/GPLD1,5,,
2,GO:0044403,GO:0044403,biological process involved in symbiotic interaction,7/33,322/18870,1.1518243097619846e-06,2.932937998515883e-05,1.925128692310788e-05,APOE/APOL1/CAMP/F2/FN1/GSN/PGLYRP2,7,,
2,GO:0043086,GO:0043086,negative regulation of catalytic activity,8/33,480/18870,1.3120420046606334e-06,3.261361554442146e-05,2.1407001128673493e-05,APOC1/APOC3/APOE/FETUB/SERPINA4/SERPINA5/SERPIND1/SERPINF2,8,,
2,GO:0010896,GO:0010896,regulation of triglyceride catabolic process,3/33,13/18870,1.3770939083935352e-06,3.31340162810767e-05,2.1748582979412113e-05,APOC2/APOC3/GPLD1,3,,
2,GO:0045833,GO:0045833,negative regulation of lipid metabolic process,5/33,112/18870,1.3995139181546182e-06,3.31340162810767e-05,2.1748582979412113e-05,APOC1/APOC2/APOC3/APOE/GPLD1,5,,
2,GO:0030195,GO:0030195,negative regulation of blood coagulation,4/33,48/18870,1.4281903569429612e-06,3.31340162810767e-05,2.1748582979412113e-05,APOE/F2/PROC/SERPINF2,4,,
2,GO:1900047,GO:1900047,negative regulation of hemostasis,4/33,49/18870,1.5532288544377717e-06,3.525154182680508e-05,2.3138489341853308e-05,APOE/F2/PROC/SERPINF2,4,,
2,GO:0050819,GO:0050819,negative regulation of coagulation,4/33,52/18870,1.9773312702525503e-06,4.3921996726460904e-05,2.8829622775686687e-05,APOE/F2/PROC/SERPINF2,4,,
2,GO:0051702,GO:0051702,biological process involved in interaction with symbiont,5/33,121/18870,2.0508423855166065e-06,4.460582188498619e-05,2.927847353007261e-05,APOE/APOL1/CAMP/F2/FN1,5,,
2,GO:0090209,GO:0090209,negative regulation of triglyceride metabolic process,3/33,15/18870,2.1856109933627705e-06,4.6566895450423115e-05,3.056568757635153e-05,APOC3/APOE/GPLD1,3,,
2,GO:0050878,GO:0050878,regulation of body fluid levels,7/33,365/18870,2.649003907585181e-06,5.432469853016062e-05,3.565777247744965e-05,APOE/F2/F7/F9/PROC/SERPIND1/SERPINF2,7,,
2,GO:0051004,GO:0051004,regulation of lipoprotein lipase activity,3/33,16/18870,2.686776239160195e-06,5.432469853016062e-05,3.565777247744965e-05,APOC1/APOC2/APOC3,3,,
2,GO:0010951,GO:0010951,negative regulation of endopeptidase activity,5/33,128/18870,2.7058278961382684e-06,5.432469853016062e-05,3.565777247744965e-05,FETUB/SERPINA4/SERPINA5/SERPIND1/SERPINF2,5,,
2,GO:0045861,GO:0045861,negative regulation of proteolysis,6/33,235/18870,2.9253893393820207e-06,5.762465038329867e-05,3.782380258068909e-05,F2/FETUB/SERPINA4/SERPINA5/SERPIND1/SERPINF2,6,,
2,GO:0061041,GO:0061041,regulation of wound healing,5/33,133/18870,3.2668079274008218e-06,6.315828659641588e-05,4.14559836401157e-05,APOE/F2/F7/PROC/SERPINF2,5,,
2,GO:0006639,GO:0006639,acylglycerol metabolic process,5/33,134/18870,3.3892262565485314e-06,6.433367657884848e-05,4.222748886149462e-05,APOC1/APOC2/APOC3/APOE/GPLD1,5,,
2,GO:0006638,GO:0006638,neutral lipid metabolic process,5/33,135/18870,3.515222726375097e-06,6.438407940939651e-05,4.226057238910782e-05,APOC1/APOC2/APOC3/APOE/GPLD1,5,,
2,GO:0042157,GO:0042157,lipoprotein metabolic process,5/33,135/18870,3.515222726375097e-06,6.438407940939651e-05,4.226057238910782e-05,APOC1/APOC3/APOE/APOL1/LCAT,5,,
2,GO:0050994,GO:0050994,regulation of lipid catabolic process,4/33,61/18870,3.7695830869398234e-06,6.685583348352662e-05,4.388298810019746e-05,APOC1/APOC2/APOC3/GPLD1,4,,
2,GO:0010466,GO:0010466,negative regulation of peptidase activity,5/33,137/18870,3.7782511259847422e-06,6.685583348352662e-05,4.388298810019746e-05,FETUB/SERPINA4/SERPINA5/SERPIND1/SERPINF2,5,,
2,GO:0046486,GO:0046486,glycerolipid metabolic process,7/33,390/18870,4.100825280347223e-06,7.135435987804168e-05,4.683574135975513e-05,APOC1/APOC2/APOC3/APOE/GPLD1/LCAT/PON1,7,,
2,GO:0046503,GO:0046503,glycerolipid catabolic process,4/33,65/18870,4.866550150655244e-06,8.328980913580451e-05,5.466995941460853e-05,APOC1/APOC2/APOC3/GPLD1,4,,
2,GO:0010985,GO:0010985,negative regulation of lipoprotein particle clearance,3/33,21/18870,6.3431563511474365e-06,0.0001068105682354504,7.010857019689273e-05,APOC1/APOC2/APOC3,3,,
2,GO:0032368,GO:0032368,regulation of lipid transport,5/33,153/18870,6.485146475653908e-06,0.00010746814159655048,7.054018973518287e-05,APOC1/APOC2/APOC3/APOE/PON1,5,,
2,GO:0061045,GO:0061045,negative regulation of wound healing,4/33,75/18870,8.629841126197633e-06,0.0001407742833710989,9.240175284793848e-05,APOE/F2/PROC/SERPINF2,4,,
2,GO:0046470,GO:0046470,phosphatidylcholine metabolic process,4/33,76/18870,9.098081110825955e-06,0.00014612917968772764,9.591661219672384e-05,APOC1/GPLD1/LCAT/PON1,4,,
2,GO:0052548,GO:0052548,regulation of endopeptidase activity,6/33,288/18870,9.395242769243763e-06,0.00014861565834985589,9.754869286726779e-05,FETUB/GSN/SERPINA4/SERPINA5/SERPIND1/SERPINF2,6,,
2,GO:0030100,GO:0030100,regulation of endocytosis,6/33,291/18870,9.96641390355155e-06,0.0001552975539598182,0.00010193457111095145,APOC1/APOC2/APOC3/APOE/CLU/COLEC11,6,,
2,GO:1903034,GO:1903034,regulation of response to wounding,5/33,173/18870,1.1783423176907045e-05,0.00018091020289251404,0.0001187462614267258,APOE/F2/F7/PROC/SERPINF2,5,,
2,GO:0055088,GO:0055088,lipid homeostasis,5/33,175/18870,1.2457948807165649e-05,0.00018849418195189763,0.00012372425131143916,APOC2/APOC3/APOC4/APOE/LCAT,5,,
2,GO:0050995,GO:0050995,negative regulation of lipid catabolic process,3/33,27/18870,1.385072979402502e-05,0.00020657374149945886,0.00013559135482571862,APOC1/APOC3/GPLD1,3,,
2,GO:0052547,GO:0052547,regulation of peptidase activity,6/33,312/18870,1.4803809539593145e-05,0.0002156811310224728,0.0001415692844279389,FETUB/GSN/SERPINA4/SERPINA5/SERPIND1/SERPINF2,6,,
2,GO:0019433,GO:0019433,triglyceride catabolic process,3/33,28/18870,1.5494334125177644e-05,0.0002156811310224728,0.0001415692844279389,APOC2/APOC3/GPLD1,3,,
2,GO:0030194,GO:0030194,positive regulation of blood coagulation,3/33,28/18870,1.5494334125177644e-05,0.0002156811310224728,0.0001415692844279389,F2/F7/SERPINF2,3,,
2,GO:0051873,GO:0051873,killing by host of symbiont cells,3/33,28/18870,1.5494334125177644e-05,0.0002156811310224728,0.0001415692844279389,APOL1/CAMP/F2,3,,
2,GO:1900048,GO:1900048,positive regulation of hemostasis,3/33,28/18870,1.5494334125177644e-05,0.0002156811310224728,0.0001415692844279389,F2/F7/SERPINF2,3,,
2,GO:0046890,GO:0046890,regulation of lipid biosynthetic process,5/33,189/18870,1.8067490176441275e-05,0.00024819025979216697,0.00016290770228342483,APOC1/APOC2/APOC3/APOE/GPLD1,5,,
2,GO:0050820,GO:0050820,positive regulation of coagulation,3/33,30/18870,1.9156651186118317e-05,0.0002583815315316426,0.00016959707302591182,F2/F7/SERPINF2,3,,
2,GO:0008202,GO:0008202,steroid metabolic process,6/33,327/18870,1.9304367298341115e-05,0.0002583815315316426,0.00016959707302591182,APOC1/APOE/APOF/APOL1/LCAT/PON1,6,,
2,GO:0032372,GO:0032372,negative regulation of sterol transport,3/33,31/18870,2.118388209438319e-05,0.0002764496613317007,0.000181456674255835,APOC1/APOC2/APOC3,3,,
2,GO:0032375,GO:0032375,negative regulation of cholesterol transport,3/33,31/18870,2.118388209438319e-05,0.0002764496613317007,0.000181456674255835,APOC1/APOC2/APOC3,3,,
2,GO:1903035,GO:1903035,negative regulation of response to wounding,4/33,97/18870,2.3944179026901607e-05,0.0003086138630133985,0.00020256868806384597,APOE/F2/PROC/SERPINF2,4,,
2,GO:0019216,GO:0019216,regulation of lipid metabolic process,6/33,342/18870,2.485199193655569e-05,0.0003164082875824895,0.00020768481066364255,APOC1/APOC2/APOC3/APOE/F2/GPLD1,6,,
2,GO:0042632,GO:0042632,cholesterol homeostasis,4/33,100/18870,2.6998310143974218e-05,0.00033959320229288054,0.00022290297912146124,APOC2/APOC3/APOE/LCAT,4,,
2,GO:0055092,GO:0055092,sterol homeostasis,4/33,101/18870,2.8077100006510166e-05,0.00034514057704395355,0.00022654417791451276,APOC2/APOC3/APOE/LCAT,4,,
2,GO:0030212,GO:0030212,hyaluronan metabolic process,3/33,34/18870,2.8100525908751005e-05,0.00034514057704395355,0.00022654417791451276,ITIH1/ITIH2/ITIH5,3,,
2,GO:0015914,GO:0015914,phospholipid transport,4/33,103/18870,3.0329164357794075e-05,0.0003681819487155467,0.000241668127257331,APOC1/APOC2/APOC3/APOE,4,,
2,GO:0048261,GO:0048261,negative regulation of receptor-mediated endocytosis,3/33,37/18870,3.6357253549775343e-05,0.0004362870425973041,0.0002863711078149274,APOC1/APOC2/APOC3,3,,
2,GO:0046461,GO:0046461,neutral lipid catabolic process,3/33,38/18870,3.9426575471760046e-05,0.0004624870201406459,0.0003035683102556569,APOC2/APOC3/GPLD1,3,,
2,GO:0046464,GO:0046464,acylglycerol catabolic process,3/33,38/18870,3.9426575471760046e-05,0.0004624870201406459,0.0003035683102556569,APOC2/APOC3/GPLD1,3,,
2,GO:0006066,GO:0006066,alcohol metabolic process,6/33,373/18870,4.040339614491295e-05,0.0004686793952809902,0.0003076328759103898,APOC1/APOE/APOF/APOL1/LCAT/PON1,6,,
2,GO:0030203,GO:0030203,glycosaminoglycan metabolic process,4/33,112/18870,4.213630203246489e-05,0.0004834098826581687,0.00031730170761289355,ITIH1/ITIH2/ITIH5/PGLYRP2,4,,
2,GO:0048259,GO:0048259,regulation of receptor-mediated endocytosis,4/33,115/18870,4.6729772725867227e-05,0.0005302813339761454,0.0003480673002807731,APOC1/APOC2/APOC3/CLU,4,,
2,GO:0006022,GO:0006022,aminoglycan metabolic process,4/33,121/18870,5.700156613281483e-05,0.0006398885488457923,0.00042001153992600405,ITIH1/ITIH2/ITIH5/PGLYRP2,4,,
2,GO:0016485,GO:0016485,protein processing,5/33,245/18870,6.2458562349566e-05,0.0006936887137547543,0.0004553250178003077,CPN1/F7/F9/GSN/SERPINF2,5,,
2,GO:0006898,GO:0006898,receptor-mediated endocytosis,5/33,258/18870,7.975579608095651e-05,0.000859710791828199,0.0005642989770923145,APOC1/APOC2/APOC3/APOE/CLU,5,,
2,GO:0006953,GO:0006953,acute-phase response,3/33,48/18870,7.987734368518706e-05,0.000859710791828199,0.0005642989770923145,F2/FN1/SERPINF2,3,,
2,GO:0032369,GO:0032369,negative regulation of lipid transport,3/33,48/18870,7.987734368518706e-05,0.000859710791828199,0.0005642989770923145,APOC1/APOC2/APOC3,3,,
2,GO:0045834,GO:0045834,positive regulation of lipid metabolic process,4/33,145/18870,0.0001150892430903582,0.001226052752921775,0.0008047593689776927,APOC2/APOE/F2/GPLD1,4,,
2,GO:0042304,GO:0042304,regulation of fatty acid biosynthetic process,3/33,55/18870,0.00012015393989748726,0.0012670779116462291,0.0008316875584610762,APOC1/APOC2/APOC3,3,,
2,GO:0015748,GO:0015748,organophosphate ester transport,4/33,152/18870,0.00013805173285010288,0.001441260090955074,0.0009460176640570208,APOC1/APOC2/APOC3/APOE,4,,
2,GO:0010982,GO:0010982,regulation of high-density lipoprotein particle clearance,2/33,11/18870,0.00016151910132999672,0.0016695637800843227,0.0010958721726506292,APOC3/GPLD1,2,,
2,GO:0090303,GO:0090303,positive regulation of wound healing,3/33,62/18870,0.00017177441271498762,0.0017581616360239907,0.001154026240221434,F2/F7/SERPINF2,3,,
2,GO:0034379,GO:0034379,very-low-density lipoprotein particle assembly,2/33,12/18870,0.0001936108081220203,0.001962424113392128,0.0012881005220994914,APOC1/APOC3,2,,
2,GO:1905953,GO:1905953,negative regulation of lipid localization,3/33,66/18870,0.0002068496733493553,0.002076452490160836,0.0013629467343160963,APOC1/APOC2/APOC3,3,,
2,GO:0051055,GO:0051055,negative regulation of lipid biosynthetic process,3/33,68/18870,0.00022600148064421587,0.0022094364610701464,0.0014502350636788318,APOC1/APOC3/APOE,3,,
2,GO:0034380,GO:0034380,high-density lipoprotein particle assembly,2/33,13/18870,0.00022856239252449793,0.0022094364610701464,0.0014502350636788318,APOE/LCAT,2,,
2,GO:0051918,GO:0051918,negative regulation of fibrinolysis,2/33,13/18870,0.00022856239252449793,0.0022094364610701464,0.0014502350636788318,F2/SERPINF2,2,,
2,GO:1905907,GO:1905907,negative regulation of amyloid fibril formation,2/33,13/18870,0.00022856239252449793,0.0022094364610701464,0.0014502350636788318,APOE/CLU,2,,
2,GO:1902905,GO:1902905,positive regulation of supramolecular fiber organization,4/33,175/18870,0.00023704563394399104,0.002270418732454373,0.0014902627493726527,APOE/CLU/GSN/SERPINF2,4,,
2,GO:0016042,GO:0016042,lipid catabolic process,5/33,334/18870,0.00026626935353712603,0.002527138228115996,0.001658768891413101,APOC1/APOC2/APOC3/APOE/GPLD1,5,,
2,GO:0062012,GO:0062012,regulation of small molecule metabolic process,5/33,337/18870,0.0002774843731893787,0.002609853023510913,0.0017130614219657237,APOC1/APOC2/APOC3/APOE/GPLD1,5,,
2,GO:0045806,GO:0045806,negative regulation of endocytosis,3/33,75/18870,0.00030198219149583965,0.002814905427871934,0.0018476541979679665,APOC1/APOC2/APOC3,3,,
2,GO:1903036,GO:1903036,positive regulation of response to wounding,3/33,77/18870,0.00032636043209012565,0.0030152238150627534,0.001979139648725401,F2/F7/SERPINF2,3,,
2,GO:0060191,GO:0060191,regulation of lipase activity,3/33,78/18870,0.0003390112296567936,0.0031046291558043198,0.0020378237350560722,APOC1/APOC2/APOC3,3,,
2,GO:0051044,GO:0051044,positive regulation of membrane protein ectodomain proteolysis,2/33,16/18870,0.00035048159971899374,0.003181763392231561,0.002088453285282059,APOE/GPLD1,2,,
2,GO:0010544,GO:0010544,negative regulation of platelet activation,2/33,17/18870,0.0003967779963270409,0.003480976707272527,0.002284851619716087,APOE/F2,2,,
2,GO:0032488,GO:0032488,Cdc42 protein signal transduction,2/33,17/18870,0.0003967779963270409,0.003480976707272527,0.002284851619716087,APOC3/APOE,2,,
2,GO:0060192,GO:0060192,negative regulation of lipase activity,2/33,17/18870,0.0003967779963270409,0.003480976707272527,0.002284851619716087,APOC1/APOC3,2,,
2,GO:1905906,GO:1905906,regulation of amyloid fibril formation,2/33,17/18870,0.0003967779963270409,0.003480976707272527,0.002284851619716087,APOE/CLU,2,,
2,GO:0051917,GO:0051917,regulation of fibrinolysis,2/33,18/18870,0.00044588703470376954,0.003879217201922795,0.0025462496455452106,F2/SERPINF2,2,,
2,GO:0006644,GO:0006644,phospholipid metabolic process,5/33,375/18870,0.0004529841701440883,0.0039083923440531255,0.002565399693464998,APOC1/APOC2/GPLD1/LCAT/PON1,5,,
2,GO:0046889,GO:0046889,positive regulation of lipid biosynthetic process,3/33,90/18870,0.00051609649942389,0.004416432339332305,0.002898868171915034,APOC2/APOE/GPLD1,3,,
2,GO:0031640,GO:0031640,killing of cells of another organism,3/33,92/18870,0.0005503696861255681,0.004577903060582948,0.003004854700987597,APOL1/CAMP/F2,3,,
2,GO:0141061,GO:0141061,disruption of cell in another organism,3/33,92/18870,0.0005503696861255681,0.004577903060582948,0.003004854700987597,APOL1/CAMP/F2,3,,
2,GO:1903510,GO:1903510,mucopolysaccharide metabolic process,3/33,92/18870,0.0005503696861255681,0.004577903060582948,0.003004854700987597,ITIH1/ITIH2/ITIH5,3,,
2,GO:1900221,GO:1900221,regulation of amyloid-beta clearance,2/33,20/18870,0.0005525055417944936,0.004577903060582948,0.003004854700987597,APOE/CLU,2,,
2,GO:0044242,GO:0044242,cellular lipid catabolic process,4/33,223/18870,0.000593660761538879,0.004842045586301482,0.0031782331888306767,APOC1/APOC2/APOC3/GPLD1,4,,
2,GO:0050866,GO:0050866,negative regulation of cell activation,4/33,223/18870,0.000593660761538879,0.004842045586301482,0.0031782331888306767,APOE/F2/FN1/PGLYRP2,4,,
2,GO:0090208,GO:0090208,positive regulation of triglyceride metabolic process,2/33,22/18870,0.000670262355703137,0.005424448832202132,0.0035605123913728456,APOC2/GPLD1,2,,
2,GO:0141060,GO:0141060,disruption of anatomical structure in another organism,3/33,99/18870,0.0006817122817508281,0.005474674016522034,0.003593479315139993,APOL1/CAMP/F2,3,,
2,GO:0019217,GO:0019217,regulation of fatty acid metabolic process,3/33,100/18870,0.000701961167470627,0.005594255410987287,0.003671970430079375,APOC1/APOC2/APOC3,3,,
2,GO:0051043,GO:0051043,regulation of membrane protein ectodomain proteolysis,2/33,24/18870,0.0007990830695469573,0.006320020640962299,0.0041483499064997546,APOE/GPLD1,2,,
2,GO:0002526,GO:0002526,acute inflammatory response,3/33,107/18870,0.0008545102446646988,0.006707584176165004,0.004402739764754404,F2/FN1/SERPINF2,3,,
2,GO:0032967,GO:0032967,positive regulation of collagen biosynthetic process,2/33,26/18870,0.0009388936333755515,0.007260777431437599,0.004765846045438472,F2/SERPINF2,2,,
2,GO:0045717,GO:0045717,negative regulation of fatty acid biosynthetic process,2/33,26/18870,0.0009388936333755515,0.007260777431437599,0.004765846045438472,APOC1/APOC3,2,,
2,GO:1905954,GO:1905954,positive regulation of lipid localization,3/33,111/18870,0.0009504211884526036,0.007295880299592045,0.004788886948008088,APOC4/APOE/PON1,3,,
2,GO:0010714,GO:0010714,positive regulation of collagen metabolic process,2/33,27/18870,0.0010128970656620728,0.0076076585363395975,0.0049935326750928394,F2/SERPINF2,2,,
2,GO:0010875,GO:0010875,positive regulation of cholesterol efflux,2/33,27/18870,0.0010128970656620728,0.0076076585363395975,0.0049935326750928394,APOE/PON1,2,,
2,GO:0042730,GO:0042730,fibrinolysis,2/33,27/18870,0.0010128970656620728,0.0076076585363395975,0.0049935326750928394,F2/SERPINF2,2,,
2,GO:0006959,GO:0006959,humoral immune response,4/33,258/18870,0.0010226753035124203,0.007626235834764049,0.0050057264856134265,CAMP/CLU/COLEC11/F2,4,,
2,GO:0062014,GO:0062014,negative regulation of small molecule metabolic process,3/33,115/18870,0.0010529094870588927,0.007796010670138184,0.005117163688505706,APOC1/APOC3/APOE,3,,
2,GO:1902430,GO:1902430,negative regulation of amyloid-beta formation,2/33,29/18870,0.0011690543379902787,0.008595019217336979,0.005641618784519433,APOE/CLU,2,,
2,GO:0070723,GO:0070723,response to cholesterol,2/33,30/18870,0.0012511898870477183,0.009134561133411314,0.005995764567302648,F7/GPLD1,2,,
2,GO:0003014,GO:0003014,renal system process,3/33,126/18870,0.0013700543190173892,0.009932893812876072,0.006519776035674857,GSN/PON3/SERPINF2,3,,
2,GO:1902992,GO:1902992,negative regulation of amyloid precursor protein catabolic process,2/33,32/18870,0.0014235292484721435,0.010249410588999433,0.006727532056300294,APOE/CLU,2,,
2,GO:0019730,GO:0019730,antimicrobial humoral response,3/33,133/18870,0.0016000104049875585,0.011441170293198705,0.00750978207387816,CAMP/COLEC11/F2,3,,
2,GO:0036314,GO:0036314,response to sterol,2/33,35/18870,0.0017020729189401306,0.012006514374145245,0.00788086394189207,F7/GPLD1,2,,
2,GO:1903725,GO:1903725,regulation of phospholipid metabolic process,2/33,35/18870,0.0017020729189401306,0.012006514374145245,0.00788086394189207,APOC1/APOC2,2,,
2,GO:0006650,GO:0006650,glycerophospholipid metabolic process,4/33,298/18870,0.0017385010473604083,0.012181175123787021,0.007995508172600677,APOC1/GPLD1/LCAT/PON1,4,,
2,GO:0032373,GO:0032373,positive regulation of sterol transport,2/33,38/18870,0.002004441673618627,0.013700984986886124,0.008993084519522956,APOE/PON1,2,,
2,GO:0032376,GO:0032376,positive regulation of cholesterol transport,2/33,38/18870,0.002004441673618627,0.013700984986886124,0.008993084519522956,APOE/PON1,2,,
2,GO:0032965,GO:0032965,regulation of collagen biosynthetic process,2/33,38/18870,0.002004441673618627,0.013700984986886124,0.008993084519522956,F2/SERPINF2,2,,
2,GO:0010565,GO:0010565,regulation of cellular ketone metabolic process,3/33,144/18870,0.00200790297221607,0.013700984986886124,0.008993084519522956,APOC1/APOC2/APOC3,3,,
2,GO:0046434,GO:0046434,organophosphate catabolic process,3/33,146/18870,0.0020883753402222206,0.014157557501246741,0.00929277065266347,APOC1/APOC2/PON1,3,,
2,GO:0097242,GO:0097242,amyloid-beta clearance,2/33,39/18870,0.0021104838584571424,0.01421512998857585,0.00933056021633684,APOE/CLU,2,,
2,GO:0062013,GO:0062013,positive regulation of small molecule metabolic process,3/33,147/18870,0.0021293551902945933,0.014250300119663818,0.00935364526910783,APOC2/APOE/GPLD1,3,,
2,GO:0045922,GO:0045922,negative regulation of fatty acid metabolic process,2/33,42/18870,0.0024442433798641163,0.016150570180874287,0.0106009489692974,APOC1/APOC3,2,,
2,GO:0071634,GO:0071634,regulation of transforming growth factor beta production,2/33,42/18870,0.0024442433798641163,0.016150570180874287,0.0106009489692974,FN1/SERPINF2,2,,
2,GO:0045807,GO:0045807,positive regulation of endocytosis,3/33,155/18870,0.002475325125668859,0.016253078183637037,0.010668233411522194,APOE/CLU/COLEC11,3,,
2,GO:0010712,GO:0010712,regulation of collagen metabolic process,2/33,43/18870,0.00256067796397812,0.016708423714957232,0.010967114174669449,F2/SERPINF2,2,,
2,GO:0006509,GO:0006509,membrane protein ectodomain proteolysis,2/33,44/18870,0.002679688517526213,0.017376365293772462,0.011405539227914773,APOE/GPLD1,2,,
2,GO:0071604,GO:0071604,transforming growth factor beta production,2/33,45/18870,0.0028012662311449384,0.018052604600711827,0.011849410763322644,FN1/SERPINF2,2,,
2,GO:1902904,GO:1902904,negative regulation of supramolecular fiber organization,3/33,167/18870,0.0030564498558119397,0.019576280058083834,0.01284952441804051,APOE/CLU/GSN,3,,
2,GO:0006633,GO:0006633,fatty acid biosynthetic process,3/33,168/18870,0.003108334779848441,0.019578962847376074,0.01285128535354086,APOC1/APOC2/APOC3,3,,
2,GO:0045862,GO:0045862,positive regulation of proteolysis,4/33,350/18870,0.003113130107916119,0.019578962847376074,0.01285128535354086,APOE/CLU/GPLD1/GSN,4,,
2,GO:0051235,GO:0051235,maintenance of location,4/33,350/18870,0.003113130107916119,0.019578962847376074,0.01285128535354086,APOC4/APOE/F2/GSN,4,,
2,GO:0032964,GO:0032964,collagen biosynthetic process,2/33,48/18870,0.0031813145582946507,0.019769597612259614,0.01297641464567555,F2/SERPINF2,2,,
2,GO:1902003,GO:1902003,regulation of amyloid-beta formation,2/33,48/18870,0.0031813145582946507,0.019769597612259614,0.01297641464567555,APOE/CLU,2,,
2,GO:0007009,GO:0007009,plasma membrane organization,3/33,170/18870,0.003213729149401927,0.019852859360802434,0.013031066186612608,CLU/GSN/SERPINA5,3,,
2,GO:0010543,GO:0010543,regulation of platelet activation,2/33,49/18870,0.0033130732442590762,0.02022718401758173,0.013276766278932955,APOE/F2,2,,
2,GO:0035987,GO:0035987,endodermal cell differentiation,2/33,49/18870,0.0033130732442590762,0.02022718401758173,0.013276766278932955,COL6A1/FN1,2,,
2,GO:0009395,GO:0009395,phospholipid catabolic process,2/33,54/18870,0.004009544829467391,0.024196328335051767,0.01588204249457421,APOC1/APOC2,2,,
2,GO:0010874,GO:0010874,regulation of cholesterol efflux,2/33,54/18870,0.004009544829467391,0.024196328335051767,0.01588204249457421,APOE/PON1,2,,
2,GO:1902991,GO:1902991,regulation of amyloid precursor protein catabolic process,2/33,55/18870,0.004156314296998329,0.024937885781989973,0.01636878770324206,APOE/CLU,2,,
2,GO:0034205,GO:0034205,amyloid-beta formation,2/33,56/18870,0.0043055554189317434,0.025685713470655656,0.016859648587816935,APOE/CLU,2,,
2,GO:0043113,GO:0043113,receptor clustering,2/33,57/18870,0.004457259638829322,0.026439653766692113,0.017354521679891675,APOE/GSN,2,,
2,GO:1902903,GO:1902903,regulation of supramolecular fiber organization,4/33,389/18870,0.004536477461524294,0.026757528078143297,0.017563168762725637,APOE/CLU/GSN/SERPINF2,4,,
2,GO:0001706,GO:0001706,endoderm formation,2/33,58/18870,0.004611418421047378,0.027046746244794733,0.017753006458319596,COL6A1/FN1,2,,
2,GO:0031638,GO:0031638,zymogen activation,2/33,59/18870,0.004768023250693789,0.027654534854023978,0.018151948164921973,F9/SERPINF2,2,,
2,GO:0033619,GO:0033619,membrane protein proteolysis,2/33,59/18870,0.004768023250693789,0.027654534854023978,0.018151948164921973,APOE/GPLD1,2,,
2,GO:0031330,GO:0031330,negative regulation of cellular catabolic process,3/33,208/18870,0.0056457328840755746,0.032564337740192816,0.02137465604846292,APOC1/APOC3/GPLD1,3,,
2,GO:0050435,GO:0050435,amyloid-beta metabolic process,2/33,65/18870,0.005758544994483955,0.03303253282550137,0.02168197103186267,APOE/CLU,2,,
2,GO:0045732,GO:0045732,positive regulation of protein catabolic process,3/33,210/18870,0.0057972305591395415,0.03307272515705837,0.021708352568305098,APOE/CLU/GPLD1,3,,
2,GO:0043254,GO:0043254,regulation of protein-containing complex assembly,4/33,419/18870,0.005892526783849351,0.03343368457792784,0.021945279955869156,APOE/CLU/GSN/LCAT,4,,
2,GO:0006956,GO:0006956,complement activation,2/33,67/18870,0.006107904622258821,0.034283077557194674,0.022502806503058817,CLU/COLEC11,2,,
2,GO:0070613,GO:0070613,regulation of protein processing,2/33,67/18870,0.006107904622258821,0.034283077557194674,0.022502806503058817,GSN/SERPINF2,2,,
2,GO:0042987,GO:0042987,amyloid precursor protein catabolic process,2/33,68/18870,0.006286144111398663,0.035094836643316606,0.023035630827585307,APOE/CLU,2,,
2,GO:1903317,GO:1903317,regulation of protein maturation,2/33,71/18870,0.006835001623809746,0.037792204146052506,0.024806135207784012,GSN/SERPINF2,2,,
2,GO:0001906,GO:0001906,cell killing,3/33,223/18870,0.006841692129888816,0.037792204146052506,0.024806135207784012,APOL1/CAMP/F2,3,,
2,GO:0042180,GO:0042180,cellular ketone metabolic process,3/33,226/18870,0.0070976048578068026,0.03879528519136284,0.025464539886647722,APOC1/APOC2/APOC3,3,,
2,GO:0072330,GO:0072330,monocarboxylic acid biosynthetic process,3/33,226/18870,0.0070976048578068026,0.03879528519136284,0.025464539886647722,APOC1/APOC2/APOC3,3,,
2,GO:0051651,GO:0051651,maintenance of location in cell,3/33,237/18870,0.008084517092046554,0.043959561688003135,0.028854279752863525,APOE/F2/GSN,3,,
2,GO:0002274,GO:0002274,myeloid leukocyte activation,3/33,241/18870,0.008462512440869827,0.04577649216719222,0.030046880823595627,CAMP/CLU/FN1,3,,
2,GO:0051051,GO:0051051,negative regulation of transport,4/33,469/18870,0.008714168902714394,0.04689480584759705,0.030780922168567936,APOC1/APOC2/APOC3/APOE,4,,
2,GO:0007492,GO:0007492,endoderm development,2/33,83/18870,0.009238574665034315,0.04895975609287221,0.03213631903252653,COL6A1/FN1,2,,
2,GO:0035023,GO:0035023,regulation of Rho protein signal transduction,2/33,83/18870,0.009238574665034315,0.04895975609287221,0.03213631903252653,APOC3/APOE,2,,
2,GO:0061844,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,2/33,83/18870,0.009238574665034315,0.04895975609287221,0.03213631903252653,CAMP/F2,2,,
2,GO:0032024,GO:0032024,positive regulation of insulin secretion,2/33,84/18870,0.009453623166174778,0.0498463766943761,0.032718281133332174,F2/GPLD1,2,,
2,GO:0032102,GO:0032102,negative regulation of response to external stimulus,4/33,481/18870,0.009503403031267923,0.049857049068561365,0.03272528629122147,APOE/F2/PROC/SERPINF2,4,,
3,HALLMARK_APICAL_JUNCTION,HALLMARK_APICAL_JUNCTION,HALLMARK_APICAL_JUNCTION,5/15,200/4383,0.00038850413379800205,0.005827562006970031,0.004907420637448447,ACTA1/ACTB/MSN/PFN1/VCL,5,,
3,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,4/15,200/4383,0.0038610024097927094,0.02464435331351787,0.0207531396324361,ACTA2/FLNA/THBS1/TPM2,4,,
3,HALLMARK_PI3K_AKT_MTOR_SIGNALING,HALLMARK_PI3K_AKT_MTOR_SIGNALING,HALLMARK_PI3K_AKT_MTOR_SIGNALING,3/15,105/4383,0.004928870662703574,0.02464435331351787,0.0207531396324361,CALR/CFL1/PFN1,3,,
3,hsa04810,hsa04810,Regulation of actin cytoskeleton,6/18,230/8843,4.143655212820573e-06,0.00034392338266410753,0.0002704280244156584,ACTB/CFL1/MSN/PFN1/TMSB4X/VCL,6,Cellular Processes,Cell motility
3,hsa04820,hsa04820,Cytoskeleton in muscle cells,5/18,232/8843,7.712874898770279e-05,0.0032008430829896656,0.0025168328617039856,ACTA1/ACTB/THBS1/TPM2/VCL,5,,
3,hsa04141,hsa04141,Protein processing in endoplasmic reticulum,4/18,170/8843,0.0003267896684211361,0.0077393452652637015,0.006085471229503481,CALR/HSPA8/P4HB/PDIA3,4,Genetic Information Processing,"Folding, sorting and degradation"
3,hsa04612,hsa04612,Antigen processing and presentation,3/18,80/8843,0.0005275440342220342,0.0077393452652637015,0.006085471229503481,CALR/HSPA8/PDIA3,3,Organismal Systems,Immune system
3,hsa04814,hsa04814,Motor proteins,4/18,197/8843,0.0005721281309530645,0.0077393452652637015,0.006085471229503481,ACTA1/ACTA2/ACTB/TPM2,4,Cellular Processes,Cell motility
3,hsa04510,hsa04510,Focal adhesion,4/18,203/8843,0.0006407357163304494,0.0077393452652637015,0.006085471229503481,ACTB/FLNA/THBS1/VCL,4,Cellular Processes,Cellular community - eukaryotes
3,hsa05205,hsa05205,Proteoglycans in cancer,4/18,204/8843,0.0006527158657451314,0.0077393452652637015,0.006085471229503481,ACTB/FLNA/MSN/THBS1,4,Human Diseases,Cancer: overview
3,hsa04670,hsa04670,Leukocyte transendothelial migration,3/18,116/8843,0.0015545038955372475,0.01612797791619894,0.01268147914780386,ACTB/MSN/VCL,3,Organismal Systems,Immune system
3,hsa04145,hsa04145,Phagosome,3/18,157/8843,0.0036830274381321466,0.03396569748499646,0.026707333469496268,ACTB/CALR/THBS1,3,Cellular Processes,Transport and catabolism
3,R-HSA-114608,R-HSA-114608,Platelet degranulation,8/19,129/11009,1.9372445978404343e-11,2.465052226402369e-09,1.6096034802289606e-09,CFL1/FLNA/PFN1/PPBP/TAGLN2/THBS1/TMSB4X/VCL,8,,
3,R-HSA-76005,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,8/19,134/11009,2.6364194934784697e-11,2.465052226402369e-09,1.6096034802289606e-09,CFL1/FLNA/PFN1/PPBP/TAGLN2/THBS1/TMSB4X/VCL,8,,
3,R-HSA-76002,R-HSA-76002,"Platelet activation, signaling and aggregation",8/19,263/11009,5.742975798859474e-09,3.579788247955739e-07,2.3374919040971893e-07,CFL1/FLNA/PFN1/PPBP/TAGLN2/THBS1/TMSB4X/VCL,8,,
3,R-HSA-445355,R-HSA-445355,Smooth Muscle Contraction,3/19,45/11009,5.9079090361441496e-05,0.002519372820654103,0.0016450731618118546,ACTA2/TPM2/VCL,3,,
3,R-HSA-9020591,R-HSA-9020591,Interleukin-12 signaling,3/19,47/11009,6.736290964315783e-05,0.002519372820654103,0.0016450731618118546,CFL1/MSN/P4HB,3,,
3,R-HSA-447115,R-HSA-447115,Interleukin-12 family signaling,3/19,57/11009,0.00012023769821505482,0.0037474082610358755,0.0024469426303414667,CFL1/MSN/P4HB,3,,
3,R-HSA-195258,R-HSA-195258,RHO GTPase Effectors,5/19,326/11009,0.00018233681621976063,0.004870997804727891,0.0031806121325552235,ACTB/CFL1/FLNA/PFN1/YWHAQ,5,,
3,R-HSA-397014,R-HSA-397014,Muscle contraction,4/19,205/11009,0.0003633671760598647,0.008493707740399337,0.005546130581966356,ACTA1/ACTA2/TPM2/VCL,4,,
3,R-HSA-446353,R-HSA-446353,Cell-extracellular matrix interactions,2/19,18/11009,0.000424723322223583,0.008824806806201114,0.005762328114378437,ACTB/FLNA,2,,
3,R-HSA-901042,R-HSA-901042,Calnexin/calreticulin cycle,2/19,26/11009,0.0008947941025724153,0.016732649718104165,0.010925906936673703,CALR/PDIA3,2,,
3,R-HSA-373760,R-HSA-373760,L1CAM interactions,3/19,119/11009,0.0010516220958438386,0.017365448586512226,0.011339105184550622,ACTB/HSPA8/MSN,3,,
3,R-HSA-983170,R-HSA-983170,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",2/19,29/11009,0.0011143603371023888,0.017365448586512226,0.011339105184550622,CALR/PDIA3,2,,
3,R-HSA-532668,R-HSA-532668,N-glycan trimming in the ER and Calnexin/Calreticulin cycle,2/19,35/11009,0.001623069258642776,0.021402499405478476,0.013975175519479334,CALR/PDIA3,2,,
3,R-HSA-390522,R-HSA-390522,Striated Muscle Contraction,2/19,36/11009,0.0017167780271774178,0.021402499405478476,0.013975175519479334,ACTA1/TPM2,2,,
3,R-HSA-6802948,R-HSA-6802948,Signaling by high-kinase activity BRAF mutants,2/19,36/11009,0.0017167780271774178,0.021402499405478476,0.013975175519479334,ACTB/VCL,2,,
3,R-HSA-8950505,R-HSA-8950505,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,2/19,38/11009,0.0019117716913848112,0.022343831643059982,0.014589836592147245,CFL1/MSN,2,,
3,R-HSA-5674135,R-HSA-5674135,MAP2K and MAPK activation,2/19,40/11009,0.0021168131333286827,0.022694474245311205,0.01481879545429834,ACTB/VCL,2,,
3,R-HSA-3928662,R-HSA-3928662,EPHB-mediated forward signaling,2/19,42/11009,0.002331838131973606,0.022694474245311205,0.01481879545429834,ACTB/CFL1,2,,
3,R-HSA-9656223,R-HSA-9656223,Signaling by RAF1 mutants,2/19,43/11009,0.0024430744736015685,0.022694474245311205,0.01481879545429834,ACTB/VCL,2,,
3,R-HSA-437239,R-HSA-437239,Recycling pathway of L1,2/19,47/11009,0.0029126597961896734,0.022694474245311205,0.01481879545429834,ACTB/MSN,2,,
3,R-HSA-6802946,R-HSA-6802946,Signaling by moderate kinase activity BRAF mutants,2/19,47/11009,0.0029126597961896734,0.022694474245311205,0.01481879545429834,ACTB/VCL,2,,
3,R-HSA-6802949,R-HSA-6802949,Signaling by RAS mutants,2/19,47/11009,0.0029126597961896734,0.022694474245311205,0.01481879545429834,ACTB/VCL,2,,
3,R-HSA-6802955,R-HSA-6802955,Paradoxical activation of RAF signaling by kinase inactive BRAF,2/19,47/11009,0.0029126597961896734,0.022694474245311205,0.01481879545429834,ACTB/VCL,2,,
3,R-HSA-9649948,R-HSA-9649948,Signaling downstream of RAS mutants,2/19,47/11009,0.0029126597961896734,0.022694474245311205,0.01481879545429834,ACTB/VCL,2,,
3,R-HSA-9662361,R-HSA-9662361,Sensory processing of sound by outer hair cells of the cochlea,2/19,54/11009,0.0038280820582995115,0.02748526628134021,0.017947035680469826,ACTB/MSN,2,,
3,R-HSA-9700206,R-HSA-9700206,Signaling by ALK in cancer,2/19,55/11009,0.003968460906931474,0.02748526628134021,0.017947035680469826,MSN/VCL,2,,
3,R-HSA-9725370,R-HSA-9725370,Signaling by ALK fusions and activated point mutants,2/19,55/11009,0.003968460906931474,0.02748526628134021,0.017947035680469826,MSN/VCL,2,,
3,R-HSA-2029482,R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,2/19,61/11009,0.0048603957278773174,0.03246050003975209,0.02119571069299883,ACTB/CFL1,2,,
3,R-HSA-6802952,R-HSA-6802952,Signaling by BRAF and RAF1 fusions,2/19,67/11009,0.00583626771494754,0.03763386423086862,0.024573758799779116,ACTB/VCL,2,,
3,R-HSA-9662360,R-HSA-9662360,Sensory processing of sound by inner hair cells of the cochlea,2/19,69/11009,0.006179926952966546,0.03852154467349147,0.02515338689628489,ACTB/MSN,2,,
3,R-HSA-1445148,R-HSA-1445148,Translocation of SLC2A4 (GLUT4) to the plasma membrane,2/19,72/11009,0.00671242903927563,0.040491104204662676,0.02643944884740147,ACTB/YWHAQ,2,,
3,R-HSA-9659379,R-HSA-9659379,Sensory processing of sound,2/19,76/11009,0.0074538758774415305,0.04355858715879894,0.028442421111290053,ACTB/MSN,2,,
3,R-HSA-449147,R-HSA-449147,Signaling by Interleukins,4/19,473/11009,0.007796578147668144,0.044180609503452824,0.028848582619760917,CFL1/HSPA8/MSN/P4HB,4,,
3,R-HSA-6798695,R-HSA-6798695,Neutrophil degranulation,4/19,480/11009,0.008206311045811845,0.045134710751965144,0.029471581464835108,HSPA8/PKM/PPBP/VCL,4,,
3,R-HSA-6802957,R-HSA-6802957,Oncogenic MAPK signaling,2/19,84/11009,0.009042800627475313,0.04831439192393953,0.031547815722921396,ACTB/VCL,2,,
3,R-HSA-2029480,R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,2/19,86/11009,0.009461779354026633,0.04914868720008279,0.03209258494348215,ACTB/CFL1,2,,
3,GO:0034975,GO:0034975,protein folding in endoplasmic reticulum,3/20,11/18870,1.6708778864751835e-07,0.00015978558804088233,9.47805730097226e-05,CALR/P4HB/PDIA3,3,,
3,GO:0007015,GO:0007015,actin filament organization,7/20,464/18870,3.0522557409910664e-07,0.00015978558804088233,9.47805730097226e-05,ACTA1/CFL1/FLNA/PFN1/TAGLN2/TMSB4X/TPM2,7,,
3,GO:0070527,GO:0070527,platelet aggregation,4/20,72/18870,9.012148075639816e-07,0.0003145239678398296,0.0001865672759518418,ACTB/FLNA/PDIA3/VCL,4,,
3,GO:0150105,GO:0150105,protein localization to cell-cell junction,3/20,22/18870,1.5479329153938935e-06,0.000367831066748125,0.000218187633219116,ACTB/FLNA/VCL,3,,
3,GO:0090130,GO:0090130,tissue migration,6/20,380/18870,1.9569423534320453e-06,0.000367831066748125,0.000218187633219116,ACTA1/ACTA2/CALR/PFN1/THBS1/TMSB4X,6,,
3,GO:0010810,GO:0010810,regulation of cell-substrate adhesion,5/20,220/18870,2.766860035001929e-06,0.000367831066748125,0.000218187633219116,CALR/FLNA/P4HB/THBS1/VCL,5,,
3,GO:0034109,GO:0034109,homotypic cell-cell adhesion,4/20,96/18870,2.8629454143891756e-06,0.000367831066748125,0.000218187633219116,ACTB/FLNA/PDIA3/VCL,4,,
3,GO:0007596,GO:0007596,blood coagulation,5/20,224/18870,3.0221308221640085e-06,0.000367831066748125,0.000218187633219116,ACTB/FLNA/PDIA3/THBS1/VCL,5,,
3,GO:0050817,GO:0050817,coagulation,5/20,229/18870,3.366913573215447e-06,0.000367831066748125,0.000218187633219116,ACTB/FLNA/PDIA3/THBS1/VCL,5,,
3,GO:0007599,GO:0007599,hemostasis,5/20,231/18870,3.5131907043755967e-06,0.000367831066748125,0.000218187633219116,ACTB/FLNA/PDIA3/THBS1/VCL,5,,
3,GO:0050808,GO:0050808,synapse organization,6/20,483/18870,7.787228931697125e-06,0.00074120260831699,0.0004396617291580195,ACTB/ACTBL2/CFL1/FLNA/HSPA8/PFN1,6,,
3,GO:0030168,GO:0030168,platelet activation,4/20,133/18870,1.0469431045794994e-05,0.0009134578587456133,0.0005418389751771093,ACTB/FLNA/PDIA3/VCL,4,,
3,GO:1900026,GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,3/20,42/18870,1.1384186998361611e-05,0.0009168649067142004,0.0005438599456707167,CALR/FLNA/P4HB,3,,
3,GO:0033574,GO:0033574,response to testosterone,3/20,45/18870,1.4043063752905034e-05,0.0010502205535208265,0.0006229629785123285,CALR/MSN/THBS1,3,,
3,GO:0031589,GO:0031589,cell-substrate adhesion,5/20,356/18870,2.8530681654765246e-05,0.0019802177861696,0.0011746126716333022,CALR/FLNA/P4HB/THBS1/VCL,5,,
3,GO:0010634,GO:0010634,positive regulation of epithelial cell migration,4/20,176/18870,3.153008937754087e-05,0.0019802177861696,0.0011746126716333022,CALR/PFN1/THBS1/TMSB4X,4,,
3,GO:0050878,GO:0050878,regulation of body fluid levels,5/20,365/18870,3.215253329979294e-05,0.0019802177861696,0.0011746126716333022,ACTB/FLNA/PDIA3/THBS1/VCL,5,,
3,GO:1900024,GO:1900024,regulation of substrate adhesion-dependent cell spreading,3/20,61/18870,3.523421551649994e-05,0.0020494568692097466,0.0012156834593412258,CALR/FLNA/P4HB,3,,
3,GO:0099173,GO:0099173,postsynapse organization,4/20,196/18870,4.800841870767911e-05,0.0026455165466810543,0.0015692502513867407,ACTB/ACTBL2/CFL1/HSPA8,4,,
3,GO:0042060,GO:0042060,wound healing,5/20,423/18870,6.489823495538524e-05,0.003368875649149226,0.0019983276861187784,ACTB/FLNA/PDIA3/THBS1/VCL,5,,
3,GO:0002064,GO:0002064,epithelial cell development,4/20,214/18870,6.757057175944006e-05,0.003368875649149226,0.0019983276861187784,ACTA2/FLNA/MSN/VCL,4,,
3,GO:0006457,GO:0006457,protein folding,4/20,223/18870,7.927883961789962e-05,0.0036062363128364304,0.002139123736564112,CALR/HSPA8/P4HB/PDIA3,4,,
3,GO:0034333,GO:0034333,adherens junction assembly,2/20,13/18870,8.266444270112162e-05,0.0036062363128364304,0.002139123736564112,ACTB/VCL,2,,
3,GO:0098761,GO:0098761,cellular response to interleukin-7,2/20,13/18870,8.266444270112162e-05,0.0036062363128364304,0.002139123736564112,P4HB/PDIA3,2,,
3,GO:0098760,GO:0098760,response to interleukin-7,2/20,14/18870,9.638053998149566e-05,0.004036417014425038,0.002394295519540313,P4HB/PDIA3,2,,
3,GO:0010763,GO:0010763,positive regulation of fibroblast migration,2/20,15/18870,0.00011113762104913214,0.004475426509170821,0.002654704308461051,ACTA2/THBS1,2,,
3,GO:0001667,GO:0001667,ameboidal-type cell migration,5/20,497/18870,0.00013877155427221267,0.005375848955611323,0.003188811022782567,ACTA2/CALR/PFN1/THBS1/TMSB4X,5,,
3,GO:0098974,GO:0098974,postsynaptic actin cytoskeleton organization,2/20,17/18870,0.00014376673424748522,0.005375848955611323,0.003188811022782567,ACTB/ACTBL2,2,,
3,GO:0034446,GO:0034446,substrate adhesion-dependent cell spreading,3/20,100/18870,0.00015418625122248642,0.005463573318715618,0.003240846788359941,CALR/FLNA/P4HB,3,,
3,GO:0034976,GO:0034976,response to endoplasmic reticulum stress,4/20,266/18870,0.00015654937875975985,0.005463573318715618,0.003240846788359941,CALR/P4HB/PDIA3/THBS1,4,,
3,GO:1902414,GO:1902414,protein localization to cell junction,3/20,108/18870,0.00019361984006923826,0.00617323060992118,0.003661796672048958,ACTB/FLNA/VCL,3,,
3,GO:0002396,GO:0002396,MHC protein complex assembly,2/20,20/18870,0.00020046785170708704,0.00617323060992118,0.003661796672048958,CALR/PDIA3,2,,
3,GO:0002501,GO:0002501,peptide antigen assembly with MHC protein complex,2/20,20/18870,0.00020046785170708704,0.00617323060992118,0.003661796672048958,CALR/PDIA3,2,,
3,GO:0099188,GO:0099188,postsynaptic cytoskeleton organization,2/20,20/18870,0.00020046785170708704,0.00617323060992118,0.003661796672048958,ACTB/ACTBL2,2,,
3,GO:0044794,GO:0044794,positive regulation by host of viral process,2/20,21/18870,0.0002214289145035113,0.006623887813862181,0.003929114573145012,CFL1/HSPA8,2,,
3,GO:0010632,GO:0010632,regulation of epithelial cell migration,4/20,295/18870,0.00023270237248024036,0.00670677926993296,0.003978283586447942,CALR/PFN1/THBS1/TMSB4X,4,,
3,GO:0019882,GO:0019882,antigen processing and presentation,3/20,116/18870,0.00023908332912418173,0.00670677926993296,0.003978283586447942,CALR/PDIA3/THBS1,3,,
3,GO:0051220,GO:0051220,cytoplasmic sequestering of protein,2/20,22/18870,0.0002434170126623233,0.00670677926993296,0.003978283586447942,FLNA/TMSB4X,2,,
3,GO:0010811,GO:0010811,positive regulation of cell-substrate adhesion,3/20,123/18870,0.0002841087603650548,0.007602957769355596,0.004509872903955966,CALR/FLNA/P4HB,3,,
3,GO:2001026,GO:2001026,regulation of endothelial cell chemotaxis,2/20,24/18870,0.00029046639042428255,0.007602957769355596,0.004509872903955966,THBS1/TMSB4X,2,,
3,GO:0071675,GO:0071675,regulation of mononuclear cell migration,3/20,125/18870,0.00029790938870933264,0.0076075885360651525,0.0045126197519513795,CALR/MSN/THBS1,3,,
3,GO:0010595,GO:0010595,positive regulation of endothelial cell migration,3/20,130/18870,0.00033428978414385053,0.00800716921265354,0.0047496404116680125,CALR/THBS1/TMSB4X,3,,
3,GO:0031647,GO:0031647,regulation of protein stability,4/20,325/18870,0.00033649994780969984,0.00800716921265354,0.0047496404116680125,CALR/FLNA/HSPA8/PFN1,4,,
3,GO:0060326,GO:0060326,cell chemotaxis,4/20,325/18870,0.00033649994780969984,0.00800716921265354,0.0047496404116680125,CALR/PPBP/THBS1/TMSB4X,4,,
3,GO:0048545,GO:0048545,response to steroid hormone,4/20,330/18870,0.0003565733303412736,0.008296272819273632,0.004921129003540384,ACTA1/CALR/HSPA8/THBS1,4,,
3,GO:0006936,GO:0006936,muscle contraction,4/20,351/18870,0.0004503775657658149,0.01025098502949583,0.006080612443977821,ACTA1/ACTA2/FLNA/TPM2,4,,
3,GO:0050921,GO:0050921,positive regulation of chemotaxis,3/20,145/18870,0.0004603041298047376,0.01025400901926724,0.006082406194508291,CALR/THBS1/TMSB4X,3,,
3,GO:0031333,GO:0031333,negative regulation of protein-containing complex assembly,3/20,147/18870,0.0004791038455918912,0.010410179363605967,0.006175042300836998,HSPA8/PFN1/TMSB4X,3,,
3,GO:0035767,GO:0035767,endothelial cell chemotaxis,2/20,31/18870,0.00048720037136264785,0.010410179363605967,0.006175042300836998,THBS1/TMSB4X,2,,
3,GO:0010631,GO:0010631,epithelial cell migration,4/20,372/18870,0.0005606858605375602,0.011740761919656511,0.006964308583519169,CALR/PFN1/THBS1/TMSB4X,4,,
3,GO:0090132,GO:0090132,epithelium migration,4/20,375/18870,0.0005778834691330858,0.011863607689849823,0.007037177436295575,CALR/PFN1/THBS1/TMSB4X,4,,
3,GO:0032970,GO:0032970,regulation of actin filament-based process,4/20,379/18870,0.0006013958130465064,0.012108873389609465,0.007182662544482566,ACTA2/FLNA/PFN1/TMSB4X,4,,
3,GO:0002474,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,2/20,36/18870,0.0006579841567160892,0.012857864805591592,0.0076269443877736275,CALR/PDIA3,2,,
3,GO:1902903,GO:1902903,regulation of supramolecular fiber organization,4/20,389/18870,0.0006631563510047239,0.012857864805591592,0.0076269443877736275,FLNA/HSPA8/PFN1/TMSB4X,4,,
3,GO:1902904,GO:1902904,negative regulation of supramolecular fiber organization,3/20,167/18870,0.0006947547261167197,0.013023097273035609,0.007724955905183741,HSPA8/PFN1/TMSB4X,3,,
3,GO:0050867,GO:0050867,positive regulation of cell activation,4/20,396/18870,0.0007089938343486434,0.013023097273035609,0.007724955905183741,ACTA2/ACTB/FLNA/THBS1,4,,
3,GO:0050900,GO:0050900,leukocyte migration,4/20,396/18870,0.0007089938343486434,0.013023097273035609,0.007724955905183741,CALR/MSN/PPBP/THBS1,4,,
3,GO:0035633,GO:0035633,maintenance of blood-brain barrier,2/20,38/18870,0.0007332944233994046,0.013237228643089254,0.007851972954730467,ACTB/VCL,2,,
3,GO:0010762,GO:0010762,regulation of fibroblast migration,2/20,39/18870,0.000772441088374746,0.013707556263192528,0.008130958824997326,ACTA2/THBS1,2,,
3,GO:0043254,GO:0043254,regulation of protein-containing complex assembly,4/20,419/18870,0.0008755120616784206,0.015277685476288438,0.009062317831408212,HSPA8/MSN/PFN1/TMSB4X,4,,
3,GO:0021762,GO:0021762,substantia nigra development,2/20,44/18870,0.000983012348389996,0.016600224657489126,0.009846812997454968,ACTB/YWHAQ,2,,
3,GO:0045022,GO:0045022,early endosome to late endosome transport,2/20,44/18870,0.000983012348389996,0.016600224657489126,0.009846812997454968,FLNA/MSN,2,,
3,GO:0009615,GO:0009615,response to virus,4/20,436/18870,0.0010152065634945382,0.016871766221885423,0.010007884251658772,ACTA2/CALR/CFL1/HSPA8,4,,
3,GO:0008154,GO:0008154,actin polymerization or depolymerization,3/20,196/18870,0.0011043510891575016,0.018066493599186002,0.010716564845442861,CFL1/PFN1/TMSB4X,3,,
3,GO:0003012,GO:0003012,muscle system process,4/20,452/18870,0.0011604569537023725,0.018692283546559753,0.011087766845091496,ACTA1/ACTA2/FLNA/TPM2,4,,
3,GO:0061028,GO:0061028,establishment of endothelial barrier,2/20,49/18870,0.00121813695264984,0.019035662528722127,0.011291450150249892,MSN/VCL,2,,
3,GO:0098927,GO:0098927,vesicle-mediated transport between endosomal compartments,2/20,49/18870,0.00121813695264984,0.019035662528722127,0.011291450150249892,FLNA/MSN,2,,
3,GO:0044788,GO:0044788,modulation by host of viral process,2/20,50/18870,0.0012680871756883697,0.019462487355893156,0.011544631317525724,CFL1/HSPA8,2,,
3,GO:0071674,GO:0071674,mononuclear cell migration,3/20,207/18870,0.0012923472953635575,0.019462487355893156,0.011544631317525724,CALR/MSN/THBS1,3,,
3,GO:1901654,GO:1901654,response to ketone,3/20,208/18870,0.0013103742894685663,0.019462487355893156,0.011544631317525724,CALR/MSN/THBS1,3,,
3,GO:0006935,GO:0006935,chemotaxis,4/20,468/18870,0.0013198057328256104,0.019462487355893156,0.011544631317525724,CALR/PPBP/THBS1/TMSB4X,4,,
3,GO:0042330,GO:0042330,taxis,4/20,470/18870,0.0013407519129149123,0.01949676740030435,0.011564965330698805,CALR/PPBP/THBS1/TMSB4X,4,,
3,GO:0045216,GO:0045216,cell-cell junction organization,3/20,214/18870,0.001421882274237488,0.020121589987916272,0.011935593518192933,ACTB/FLNA/VCL,3,,
3,GO:2001238,GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,2/20,53/18870,0.0014237540880950956,0.020121589987916272,0.011935593518192933,PDIA3/THBS1,2,,
3,GO:0045785,GO:0045785,positive regulation of cell adhesion,4/20,482/18870,0.0014713739045362512,0.020121589987916272,0.011935593518192933,ACTB/CALR/FLNA/P4HB,4,,
3,GO:0010761,GO:0010761,fibroblast migration,2/20,54/18870,0.0014775754652164034,0.020121589987916272,0.011935593518192933,ACTA2/THBS1,2,,
3,GO:0050821,GO:0050821,protein stabilization,3/20,217/18870,0.0014798112980607,0.020121589987916272,0.011935593518192933,CALR/FLNA/PFN1,3,,
3,GO:0034332,GO:0034332,adherens junction organization,2/20,57/18870,0.0016448102542289808,0.021798940964275225,0.012930553630847419,ACTB/VCL,2,,
3,GO:0072132,GO:0072132,mesenchyme morphogenesis,2/20,57/18870,0.0016448102542289808,0.021798940964275225,0.012930553630847419,ACTA1/ACTA2,2,,
3,GO:0002685,GO:0002685,regulation of leukocyte migration,3/20,230/18870,0.001747991661926752,0.0228762503448276,0.013569584983107912,CALR/MSN/THBS1,3,,
3,GO:0010594,GO:0010594,regulation of endothelial cell migration,3/20,231/18870,0.0017697958719494133,0.0228762503448276,0.013569584983107912,CALR/THBS1/TMSB4X,3,,
3,GO:0050920,GO:0050920,regulation of chemotaxis,3/20,232/18870,0.0017917704511886295,0.02287784954139628,0.013570533584098734,CALR/THBS1/TMSB4X,3,,
3,GO:0032233,GO:0032233,positive regulation of actin filament bundle assembly,2/20,61/18870,0.0018811842766575325,0.023447618305481387,0.013908505303608322,FLNA/PFN1,2,,
3,GO:1903670,GO:1903670,regulation of sprouting angiogenesis,2/20,61/18870,0.0018811842766575325,0.023447618305481387,0.013908505303608322,PKM/THBS1,2,,
3,GO:0051651,GO:0051651,maintenance of location in cell,3/20,237/18870,0.0019042161973621568,0.023455463042802098,0.01391315859372969,CALR/FLNA/TMSB4X,3,,
3,GO:0030595,GO:0030595,leukocyte chemotaxis,3/20,240/18870,0.001973759567459543,0.023855868801854425,0.014150668670481183,CALR/PPBP/THBS1,3,,
3,GO:0051893,GO:0051893,regulation of focal adhesion assembly,2/20,63/18870,0.002005077798054622,0.023855868801854425,0.014150668670481183,THBS1/VCL,2,,
3,GO:0090109,GO:0090109,regulation of cell-substrate junction assembly,2/20,63/18870,0.002005077798054622,0.023855868801854425,0.014150668670481183,THBS1/VCL,2,,
3,GO:0001885,GO:0001885,endothelial cell development,2/20,64/18870,0.0020684446160736674,0.024062905700323663,0.014273477467642851,MSN/VCL,2,,
3,GO:0043462,GO:0043462,regulation of ATP-dependent activity,2/20,64/18870,0.0020684446160736674,0.024062905700323663,0.014273477467642851,PFN1/TPM2,2,,
3,GO:0030837,GO:0030837,negative regulation of actin filament polymerization,2/20,66/18870,0.0021980090096320637,0.025289180583349127,0.015000871205123395,PFN1/TMSB4X,2,,
3,GO:0048857,GO:0048857,neural nucleus development,2/20,67/18870,0.0022642028500163085,0.025767612869207337,0.015284664548165013,ACTB/YWHAQ,2,,
3,GO:0034394,GO:0034394,protein localization to cell surface,2/20,68/18870,0.002331335300301006,0.025967107015054825,0.015402999184519525,FLNA/VCL,2,,
3,GO:0150116,GO:0150116,regulation of cell-substrate junction organization,2/20,68/18870,0.002331335300301006,0.025967107015054825,0.015402999184519525,THBS1/VCL,2,,
3,GO:0048002,GO:0048002,antigen processing and presentation of peptide antigen,2/20,71/18870,0.0025383457115093966,0.027975241683687768,0.01659417141042154,CALR/PDIA3,2,,
3,GO:0110053,GO:0110053,regulation of actin filament organization,3/20,273/18870,0.0028453203693302215,0.03103177527800773,0.01840722607351788,FLNA/PFN1/TMSB4X,3,,
3,GO:0043536,GO:0043536,positive regulation of blood vessel endothelial cell migration,2/20,76/18870,0.0029019620527087316,0.031323239888515896,0.018580115150278367,THBS1/TMSB4X,2,,
3,GO:1903036,GO:1903036,positive regulation of response to wounding,2/20,77/18870,0.002977458544727391,0.0318101948605059,0.018868963924695604,FLNA/THBS1,2,,
3,GO:0043542,GO:0043542,endothelial cell migration,3/20,284/18870,0.0031809636814043073,0.03360306039749313,0.019932444211050067,CALR/THBS1/TMSB4X,3,,
3,GO:0032272,GO:0032272,negative regulation of protein polymerization,2/20,80/18870,0.003209461356016536,0.03360306039749313,0.019932444211050067,PFN1/TMSB4X,2,,
3,GO:0048041,GO:0048041,focal adhesion assembly,2/20,85/18870,0.0036144006480826967,0.03746809384695627,0.0222250795452714,THBS1/VCL,2,,
3,GO:0051851,GO:0051851,modulation by host of symbiont process,2/20,87/18870,0.0037827275881145276,0.03882858612505795,0.023032087481811882,CFL1/HSPA8,2,,
3,GO:0030901,GO:0030901,midbrain development,2/20,91/18870,0.00413018941745357,0.04198357592304745,0.024903543753680184,ACTB/YWHAQ,2,,
3,GO:0001738,GO:0001738,morphogenesis of a polarized epithelium,2/20,92/18870,0.004219295986853499,0.042476950944573204,0.025196200731210164,ACTB/MSN,2,,
3,GO:0045185,GO:0045185,maintenance of protein location,2/20,93/18870,0.004309295395946148,0.04296983123386302,0.02548856424669902,FLNA/TMSB4X,2,,
3,GO:0007044,GO:0007044,cell-substrate junction assembly,2/20,95/18870,0.004491965542825396,0.04427287621912001,0.026261495972734934,THBS1/VCL,2,,
3,GO:0044403,GO:0044403,biological process involved in symbiotic interaction,3/20,322/18870,0.004524544179031366,0.04427287621912001,0.026261495972734934,CFL1/HSPA8/P4HB,3,,
3,GO:0002690,GO:0002690,positive regulation of leukocyte chemotaxis,2/20,96/18870,0.004584632691620306,0.04444546692709686,0.026363872203274668,CALR/THBS1,2,,
3,GO:0060485,GO:0060485,mesenchyme development,3/20,327/18870,0.0047233156817482955,0.04536983044761895,0.026912180127778795,ACTA1/ACTA2/FLNA,3,,
3,GO:0032956,GO:0032956,regulation of actin cytoskeleton organization,3/20,337/18870,0.005136662292054119,0.048663541068751,0.028865921912796553,FLNA/PFN1/TMSB4X,3,,
3,GO:0150115,GO:0150115,cell-substrate junction organization,2/20,102/18870,0.005159171975770164,0.048663541068751,0.028865921912796553,THBS1/VCL,2,,
3,GO:0099175,GO:0099175,regulation of postsynapse organization,2/20,103/18870,0.005258001288368912,0.04915292275823439,0.02915621015166972,CFL1/HSPA8,2,,
4,HALLMARK_COAGULATION,HALLMARK_COAGULATION,HALLMARK_COAGULATION,7/30,138/4383,2.924147583502501e-05,0.0009064857508857754,0.0006771710193374214,C1QA/CFD/CFH/F11/GP1BA/LAMP2/MST1,7,,
4,HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,6/30,200/4383,0.0019828299501700388,0.0307338642276356,0.02295908363354782,C1QA/C1QC/CFH/GP1BA/HSPA5/LAMP2,6,,
4,hsa04610,hsa04610,Complement and coagulation cascades,9/37,88/8843,6.24564172369494e-11,5.3087954651407e-09,4.602051796406799e-09,C1QA/C1QB/C1QC/C6/CFD/CFH/F11/PROCR/VTN,9,Organismal Systems,Immune system
4,hsa05150,hsa05150,Staphylococcus aureus infection,6/37,100/8843,3.1478659712125785e-06,0.00013378430377653457,0.00011597400946572657,C1QA/C1QB/C1QC/CFD/CFH/FCGR3A,6,Human Diseases,Infectious disease: bacterial
4,hsa05322,hsa05322,Systemic lupus erythematosus,5/37,139/8843,0.00025967237774849824,0.00735738403620745,0.006377918049963115,C1QA/C1QB/C1QC/C6/FCGR3A,5,Human Diseases,Immune disease
4,hsa04512,hsa04512,ECM-receptor interaction,4/37,89/8843,0.0004913186872498816,0.010440522104059984,0.009050607396708345,GP1BA/HSPG2/SPP1/VTN,4,Environmental Information Processing,Signaling molecules and interaction
4,hsa05171,hsa05171,Coronavirus disease - COVID-19,5/37,238/8843,0.0029205904885453164,0.0351453163355585,0.03046652809274421,C1QA/C1QB/C1QC/C6/CFD,5,Human Diseases,Infectious disease: viral
4,hsa04936,hsa04936,Alcoholic liver disease,4/37,144/8843,0.0029344900348031184,0.0351453163355585,0.03046652809274421,C1QA/C1QB/C1QC/CAMKK2,4,Human Diseases,Endocrine and metabolic disease
4,hsa04918,hsa04918,Thyroid hormone synthesis,3/37,75/8843,0.0037016816148243217,0.0351453163355585,0.03046652809274421,GPX3/HSPA5/SERPINA7,3,Organismal Systems,Endocrine system
4,hsa04514,hsa04514,Cell adhesion molecules,4/37,157/8843,0.004003260820880347,0.0351453163355585,0.03046652809274421,ALCAM/CADM1/ICAM2/SELL,4,Environmental Information Processing,Signaling molecules and interaction
4,hsa04614,hsa04614,Renin-angiotensin system,2/37,23/8843,0.004077861385441067,0.0351453163355585,0.03046652809274421,AGT/ANPEP,2,Organismal Systems,Endocrine system
4,hsa05133,hsa05133,Pertussis,3/37,78/8843,0.004134743098301,0.0351453163355585,0.03046652809274421,C1QA/C1QB/C1QC,3,Human Diseases,Infectious disease: bacterial
4,hsa05020,hsa05020,Prion disease,5/37,278/8843,0.005662071119959864,0.043752367745144405,0.03792774912891775,C1QA/C1QB/C1QC/C6/HSPA5,5,Human Diseases,Neurodegenerative disease
4,R-HSA-166658,R-HSA-166658,Complement cascade,9/46,58/11009,1.5496249343382134e-12,2.7118436350918737e-10,2.2673459565580176e-10,C1QA/C1QB/C1QC/C6/CFD/CFH/FCN2/FCN3/VTN,9,,
4,R-HSA-166663,R-HSA-166663,Initial triggering of complement,6/46,23/11009,3.631436297268858e-10,3.1775067601102506e-08,2.6566823437914276e-08,C1QA/C1QB/C1QC/CFD/FCN2/FCN3,6,,
4,R-HSA-166786,R-HSA-166786,Creation of C4 and C2 activators,5/46,14/11009,1.9820089272335075e-09,1.1561718742195461e-07,9.666640031068685e-08,C1QA/C1QB/C1QC/FCN2/FCN3,5,,
4,R-HSA-6798695,R-HSA-6798695,Neutrophil degranulation,14/46,480/11009,4.936468040847232e-09,2.159704767870664e-07,1.805708046520435e-07,A1BG/ALDOA/ANPEP/B2M/BST1/CD93/CFD/FUCA1/GGH/KRT1/LAMP2/LYZ/PTPRJ/SELL,14,,
4,R-HSA-977606,R-HSA-977606,Regulation of Complement cascade,6/46,47/11009,3.583844737406161e-08,1.2543456580921564e-06,1.0487461442093818e-06,C1QA/C1QB/C1QC/C6/CFH/VTN,6,,
4,R-HSA-114608,R-HSA-114608,Platelet degranulation,5/46,129/11009,0.00019062480804489626,0.005559890234642808,0.004648569880393084,A1BG/ALDOA/CFD/HSPA5/LAMP2,5,,
4,R-HSA-76005,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,5/46,134/11009,0.00022766780529959833,0.005691695132489958,0.004758770667164537,A1BG/ALDOA/CFD/HSPA5/LAMP2,5,,
4,R-HSA-216083,R-HSA-216083,Integrin cell surface interactions,4/46,85/11009,0.00042187678581404975,0.009228554689682339,0.007715904372125384,HSPG2/ICAM2/SPP1/VTN,4,,
4,R-HSA-140877,R-HSA-140877,Formation of Fibrin Clot (Clotting Cascade),3/46,39/11009,0.0005615872404850907,0.010919751898321207,0.009129897827769311,F11/GP1BA/PROCR,3,,
4,R-HSA-76002,R-HSA-76002,"Platelet activation, signaling and aggregation",6/46,263/11009,0.0007374361691424686,0.012905132959993201,0.010789855527452962,A1BG/ALDOA/CFD/GP1BA/HSPA5/LAMP2,6,,
4,R-HSA-977225,R-HSA-977225,Amyloid fiber formation,4/46,110/11009,0.001114809614728934,0.01773560750705122,0.01482856808108343,APCS/B2M/HSPG2/LYZ,4,,
4,R-HSA-9651496,R-HSA-9651496,Defects of contact activation system (CAS) and kallikrein/kinin system (KKS),2/46,16/11009,0.0019746881649737005,0.026582340682338276,0.022225235217112903,F11/GP1BA,2,,
4,R-HSA-9671793,R-HSA-9671793,Diseases of hemostasis,2/46,16/11009,0.0019746881649737005,0.026582340682338276,0.022225235217112903,F11/GP1BA,2,,
4,R-HSA-198933,R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,4/46,133/11009,0.0022432739412196153,0.028040924265245192,0.02344474269394936,B2M/FCGR3A/ICAM2/SELL,4,,
4,R-HSA-2022377,R-HSA-2022377,Metabolism of Angiotensinogen to Angiotensins,2/46,18/11009,0.002504377927443998,0.02921774248684664,0.02442866890629584,AGT/ANPEP,2,,
4,R-HSA-140837,R-HSA-140837,Intrinsic Pathway of Fibrin Clot Formation,2/46,23/11009,0.004086602038179785,0.0446972097925914,0.03737090021756514,F11/GP1BA,2,,
4,GO:0006956,GO:0006956,complement activation,10/56,67/18870,4.943818311138608e-15,5.8485370620769734e-12,4.610761077546113e-12,C1QA/C1QB/C1QC/C6/CD5L/CFD/CFH/FCN2/FCN3/KRT1,10,,
4,GO:0006959,GO:0006959,humoral immune response,13/56,258/18870,4.832665399360435e-13,2.858521583721697e-10,2.2535481809649186e-10,BST1/C1QA/C1QB/C1QC/C6/CD5L/CFD/CFH/FCN2/FCN3/HPX/KRT1/LYZ,13,,
4,GO:1903035,GO:1903035,negative regulation of response to wounding,6/56,97/18870,4.163500375889046e-07,0.00013252655797591116,0.00010447882757187996,APCS/F11/GP1BA/KRT1/SPP1/VTN,6,,
4,GO:0050819,GO:0050819,negative regulation of coagulation,5/56,52/18870,4.4810332367171987e-07,0.00013252655797591116,0.00010447882757187996,F11/GP1BA/KRT1/PROCR/VTN,5,,
4,GO:0002455,GO:0002455,humoral immune response mediated by circulating immunoglobulin,5/56,55/18870,5.957547074689643e-07,0.00014095556378715697,0.00011112393069842157,C1QA/C1QB/C1QC/C6/HPX,5,,
4,GO:0042730,GO:0042730,fibrinolysis,4/56,27/18870,1.1601386450530023e-06,0.0002287406695162836,0.0001803303227222737,F11/GP1BA/KRT1/VTN,4,,
4,GO:0050818,GO:0050818,regulation of coagulation,5/56,73/18870,2.4700875778738958e-06,0.0004174448006606884,0.0003290973825558303,F11/GP1BA/KRT1/PROCR/VTN,5,,
4,GO:0061045,GO:0061045,negative regulation of wound healing,5/56,75/18870,2.8255431714264183e-06,0.0004178271964746816,0.00032939884866892193,APCS/F11/GP1BA/KRT1/VTN,5,,
4,GO:0001867,GO:0001867,"complement activation, lectin pathway",3/56,11/18870,4.016581827889483e-06,0.0004915270881218782,0.0003875010010908789,FCN2/FCN3/KRT1,3,,
4,GO:0001906,GO:0001906,cell killing,7/56,223/18870,4.154920440590687e-06,0.0004915270881218782,0.0003875010010908789,B2M/C6/CADM1/CD5L/CFH/FCGR3A/LYZ,7,,
4,GO:0006958,GO:0006958,"complement activation, classical pathway",4/56,42/18870,7.15846743164783e-06,0.0007698606337853984,0.000606928434874639,C1QA/C1QB/C1QC/C6,4,,
4,GO:0098883,GO:0098883,synapse pruning,3/56,14/18870,8.80498505912715e-06,0.0008680247770789515,0.0006843172598584786,C1QA/C1QB/C1QC,3,,
4,GO:1903034,GO:1903034,regulation of response to wounding,6/56,173/18870,1.2091068096869989e-05,0.0009685556269640546,0.000763571905049742,APCS/F11/GP1BA/KRT1/SPP1/VTN,6,,
4,GO:0002449,GO:0002449,lymphocyte mediated immunity,8/56,368/18870,1.2168364051877488e-05,0.0009685556269640546,0.000763571905049742,B2M/C1QA/C1QB/C1QC/C6/CADM1/FCGR3A/HPX,8,,
4,GO:0030195,GO:0030195,negative regulation of blood coagulation,4/56,48/18870,1.2280925109434337e-05,0.0009685556269640546,0.000763571905049742,F11/GP1BA/KRT1/VTN,4,,
4,GO:1900047,GO:1900047,negative regulation of hemostasis,4/56,49/18870,1.3343139948762854e-05,0.0009865584099616536,0.0007777646049081507,F11/GP1BA/KRT1/VTN,4,,
4,GO:0002697,GO:0002697,regulation of immune effector process,8/56,389/18870,1.8158197970146577e-05,0.0012635969528637296,0.0009961711084551003,B2M/CADM1/CD5L/CFH/FCN2/FCN3/HPX/PTPRJ,8,,
4,GO:0016064,GO:0016064,immunoglobulin mediated immune response,6/56,205/18870,3.155864057534302e-05,0.002074103988923933,0.0016351435994008136,C1QA/C1QB/C1QC/C6/FCGR3A/HPX,6,,
4,GO:0019724,GO:0019724,B cell mediated immunity,6/56,208/18870,3.423581759247858e-05,0.002131630116415903,0.0016804949798856527,C1QA/C1QB/C1QC/C6/FCGR3A/HPX,6,,
4,GO:0061041,GO:0061041,regulation of wound healing,5/56,133/18870,4.6177724920677884e-05,0.0027314124290580967,0.002153340225248453,APCS/F11/GP1BA/KRT1/VTN,5,,
4,GO:0030193,GO:0030193,regulation of blood coagulation,4/56,68/18870,4.918580533184321e-05,0.0027708003670271677,0.0021843921565921345,F11/GP1BA/KRT1/VTN,4,,
4,GO:1900046,GO:1900046,regulation of hemostasis,4/56,70/18870,5.513386326126225e-05,0.002964698192639693,0.0023372537248554236,F11/GP1BA/KRT1/VTN,4,,
4,GO:0002443,GO:0002443,leukocyte mediated immunity,8/56,466/18870,6.539462110111508e-05,0.003257695285122488,0.002568241333468456,B2M/C1QA/C1QB/C1QC/C6/CADM1/FCGR3A/HPX,8,,
4,GO:0045123,GO:0045123,cellular extravasation,4/56,74/18870,6.858216669367414e-05,0.003257695285122488,0.002568241333468456,BST1/GP1BA/LYVE1/SELL,4,,
4,GO:0150146,GO:0150146,cell junction disassembly,3/56,27/18870,6.884394093665443e-05,0.003257695285122488,0.002568241333468456,C1QA/C1QB/C1QC,3,,
4,GO:0008037,GO:0008037,cell recognition,5/56,154/18870,9.26444340552217e-05,0.004185086979623097,0.003299361181604364,ALDOA/CADM1/FCN2/FCN3/ROBO4,5,,
4,GO:0045807,GO:0045807,positive regulation of endocytosis,5/56,155/18870,9.551762337263197e-05,0.004185086979623097,0.003299361181604364,B2M/FCN2/FCN3/PTPRJ/VTN,5,,
4,GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,7/56,380/18870,0.00012605454370891007,0.00532580447170145,0.004198658861883245,B2M/C1QA/C1QB/C1QC/C6/FCGR3A/HPX,7,,
4,GO:0002699,GO:0002699,positive regulation of immune effector process,6/56,270/18870,0.00014468023809542782,0.005901955919547969,0.004652874444738623,B2M/CADM1/FCN2/FCN3/HPX/PTPRJ,6,,
4,GO:0098742,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,6/56,279/18870,0.0001728870150916031,0.006817511295112215,0.0053746629954793115,ALCAM/CADM1/DSG2/ROBO4/SELL/SPARCL1,6,,
4,GO:0002691,GO:0002691,regulation of cellular extravasation,3/56,41/18870,0.00024361985434216804,0.009296847989896283,0.007329276432840777,BST1/GP1BA/LYVE1,3,,
4,GO:0031341,GO:0031341,regulation of cell killing,4/56,111/18870,0.00032909290327331163,0.012166153267885239,0.00959132606250507,B2M/CADM1/CD5L/CFH,4,,
4,GO:0002920,GO:0002920,regulation of humoral immune response,3/56,47/18870,0.0003659308255665403,0.013118065655915672,0.01034177707980717,CD5L/CFH/HPX,3,,
4,GO:0097278,GO:0097278,complement-dependent cytotoxicity,2/56,11/18870,0.0004676638351476434,0.015807037627990347,0.01246165888543796,CD5L/CFH,2,,
4,GO:1903027,GO:1903027,regulation of opsonization,2/56,11/18870,0.0004676638351476434,0.015807037627990347,0.01246165888543796,FCN2/FCN3,2,,
4,GO:0043086,GO:0043086,negative regulation of catalytic activity,7/56,480/18870,0.0005208532585320073,0.01638103837253549,0.012914178936749962,AGT/APCS/HEG1/PTPRJ/SERPINA7/SERPINF1/VTN,7,,
4,GO:0007157,GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,3/56,53/18870,0.0005220476298722283,0.01638103837253549,0.012914178936749962,ALCAM/CADM1/SELL,3,,
4,GO:0007596,GO:0007596,blood coagulation,5/56,224/18870,0.0005261872004702862,0.01638103837253549,0.012914178936749962,F11/GP1BA/KRT1/PROCR/VTN,5,,
4,GO:0050817,GO:0050817,coagulation,5/56,229/18870,0.0005816139617657593,0.01745565102928093,0.013761362114110344,F11/GP1BA/KRT1/PROCR/VTN,5,,
4,GO:0007599,GO:0007599,hemostasis,5/56,231/18870,0.0006049718446327288,0.01745565102928093,0.013761362114110344,F11/GP1BA/KRT1/PROCR/VTN,5,,
4,GO:0050730,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,5/56,231/18870,0.0006049718446327288,0.01745565102928093,0.013761362114110344,AGT/BST1/HPX/PTPRJ/VTN,5,,
4,GO:0050878,GO:0050878,regulation of body fluid levels,6/56,365/18870,0.0007222106154997469,0.02034226566990954,0.0160370577777638,F11/GP1BA/HEG1/KRT1/PROCR/VTN,6,,
4,GO:0008228,GO:0008228,opsonization,2/56,17/18870,0.001143259786690654,0.03145293785244288,0.024796283256007825,FCN2/FCN3,2,,
4,GO:1901184,GO:1901184,regulation of ERBB signaling pathway,3/56,70/18870,0.001177163563390753,0.03164964762480138,0.02495136165464611,AGT/CADM1/PTPRJ,3,,
4,GO:0050766,GO:0050766,positive regulation of phagocytosis,3/56,72/18870,0.0012771746571371737,0.03231152141680195,0.025473157427847597,FCN2/FCN3/PTPRJ,3,,
4,GO:0006957,GO:0006957,"complement activation, alternative pathway",2/56,18/18870,0.0012837206310986403,0.03231152141680195,0.025473157427847597,CFD/CFH,2,,
4,GO:0051917,GO:0051917,regulation of fibrinolysis,2/56,18/18870,0.0012837206310986403,0.03231152141680195,0.025473157427847597,F11/VTN,2,,
4,GO:0018108,GO:0018108,peptidyl-tyrosine phosphorylation,5/56,276/18870,0.0013412569331362903,0.03305639483125482,0.026060386902604243,AGT/BST1/HPX/PTPRJ/VTN,5,,
4,GO:0018212,GO:0018212,peptidyl-tyrosine modification,5/56,278/18870,0.0013847112822130399,0.03343088667057196,0.026355621826869034,AGT/BST1/HPX/PTPRJ/VTN,5,,
4,GO:0031343,GO:0031343,positive regulation of cell killing,3/56,76/18870,0.001492898956772954,0.03532198931724809,0.027846494225280783,B2M/CADM1/CD5L,3,,
4,GO:0042060,GO:0042060,wound healing,6/56,423/18870,0.0015426942216401481,0.03532577703014446,0.027849480312059433,APCS/F11/GP1BA/KRT1/PROCR/VTN,6,,
4,GO:0050731,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,4/56,168/18870,0.0015527814079184378,0.03532577703014446,0.027849480312059433,AGT/HPX/PTPRJ/VTN,4,,
4,GO:0030100,GO:0030100,regulation of endocytosis,5/56,291/18870,0.0016930160173367305,0.037789395254893436,0.029791701913810188,B2M/FCN2/FCN3/PTPRJ/VTN,5,,
4,GO:0001895,GO:0001895,retina homeostasis,3/56,83/18870,0.0019228206246977102,0.04063326704058037,0.03203370075895734,B2M/KRT1/LYZ,3,,
4,GO:0030449,GO:0030449,regulation of complement activation,2/56,22/18870,0.001923468262275994,0.04063326704058037,0.03203370075895734,CD5L/CFH,2,,
4,GO:2000831,GO:2000831,regulation of steroid hormone secretion,2/56,22/18870,0.001923468262275994,0.04063326704058037,0.03203370075895734,AGT/SPP1,2,,
4,GO:0043171,GO:0043171,peptide catabolic process,2/56,23/18870,0.002102652351430649,0.04288685744383548,0.033810344525726954,ANPEP/DPEP2,2,,
4,GO:0046597,GO:0046597,negative regulation of viral entry into host cell,2/56,23/18870,0.002102652351430649,0.04288685744383548,0.033810344525726954,APCS/FCN3,2,,
4,GO:0019932,GO:0019932,second-messenger-mediated signaling,5/56,310/18870,0.002230784565749945,0.044729121038681104,0.035262714099098154,AGT/BST1/CAMKK2/FCGR3A/PTPRJ,5,,
4,GO:0046716,GO:0046716,muscle cell cellular homeostasis,2/56,24/18870,0.0022894444415923775,0.045140212906729704,0.035586803074576255,ALDOA/LAMP2,2,,
4,GO:0051262,GO:0051262,protein tetramerization,3/56,90/18870,0.0024228120028702295,0.04698666556386035,0.03704247514310653,ALDOA/B2M/KRT1,3,,
5,HALLMARK_COAGULATION,HALLMARK_COAGULATION,HALLMARK_COAGULATION,7/23,138/4383,4.2366059323870756e-06,9.744193644490273e-05,8.919170383972791e-05,F10/F12/F13B/HRG/KLKB1/PLG/SERPINC1,7,,
5,HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,5/23,200/4383,0.003229627437819225,0.024760477023280728,0.022664052195222634,APOA4/F10/KLKB1/PLG/SERPINC1,5,,
5,HALLMARK_XENOBIOTIC_METABOLISM,HALLMARK_XENOBIOTIC_METABOLISM,HALLMARK_XENOBIOTIC_METABOLISM,5/23,200/4383,0.003229627437819225,0.024760477023280728,0.022664052195222634,F10/HGFAC/HRG/PLG/RBP4,5,,
5,hsa04610,hsa04610,Complement and coagulation cascades,7/20,88/8843,5.295142680876841e-10,1.4826399506455155e-08,1.170505224193828e-08,F10/F12/F13A1/F13B/KLKB1/PLG/SERPINC1,7,Organismal Systems,Immune system
5,hsa04977,hsa04977,Vitamin digestion and absorption,2/20,26/8843,0.0015288815419645294,0.02140434158750341,0.016898164411186904,APOA4/BTD,2,Organismal Systems,Digestive system
5,hsa04514,hsa04514,Cell adhesion molecules,3/20,157/8843,0.005013503076369371,0.04058803659837398,0.03204318678818999,CNTN1/ICOSLG/NCAM1,3,Environmental Information Processing,Signaling molecules and interaction
5,hsa04979,hsa04979,Cholesterol metabolism,2/20,51/8843,0.005798290942624854,0.04058803659837398,0.03204318678818999,APOA2/APOA4,2,Organismal Systems,Digestive system
5,R-HSA-140877,R-HSA-140877,Formation of Fibrin Clot (Clotting Cascade),6/28,39/11009,4.703764081764845e-10,4.750801722582493e-08,2.9212850613065877e-08,F10/F12/F13A1/F13B/KLKB1/SERPINC1,6,,
5,R-HSA-140875,R-HSA-140875,Common Pathway of Fibrin Clot Formation,4/28,22/11009,2.372706136615891e-07,9.652946848061458e-06,5.9356317252279935e-06,F10/F13A1/F13B/SERPINC1,4,,
5,R-HSA-140837,R-HSA-140837,Intrinsic Pathway of Fibrin Clot Formation,4/28,23/11009,2.86721193506776e-07,9.652946848061458e-06,5.9356317252279935e-06,F10/F12/KLKB1/SERPINC1,4,,
5,R-HSA-114608,R-HSA-114608,Platelet degranulation,6/28,129/11009,7.023972743201944e-07,1.773553117658491e-05,1.0905641890760913e-05,CLEC3B/ECM1/F13A1/HRG/PLG/SELENOP,6,,
5,R-HSA-76005,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,6/28,134/11009,8.787538319405922e-07,1.7750827405199962e-05,1.0915047596735775e-05,CLEC3B/ECM1/F13A1/HRG/PLG/SELENOP,6,,
5,R-HSA-975634,R-HSA-975634,Retinoid metabolism and transport,4/28,44/11009,4.237285302406285e-06,7.132763592383912e-05,4.385961979683698e-05,APOA2/APOA4/RBP4/TTR,4,,
5,R-HSA-6806667,R-HSA-6806667,Metabolism of fat-soluble vitamins,4/28,48/11009,6.031275746013094e-06,8.702269290676037e-05,5.351056676913873e-05,APOA2/APOA4/RBP4/TTR,4,,
5,R-HSA-9651496,R-HSA-9651496,Defects of contact activation system (CAS) and kallikrein/kinin system (KKS),3/28,16/11009,8.071119490750093e-06,9.05758965073066e-05,5.5695444439094205e-05,F10/F12/KLKB1,3,,
5,R-HSA-9671793,R-HSA-9671793,Diseases of hemostasis,3/28,16/11009,8.071119490750093e-06,9.05758965073066e-05,5.5695444439094205e-05,F10/F12/KLKB1,3,,
5,R-HSA-381426,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),5/28,125/11009,1.3883632950324612e-05,0.00014022469279827856,8.622466779675284e-05,APOA2/IGFALS/IGFBP3/PLG/SERPINC1,5,,
5,R-HSA-76002,R-HSA-76002,"Platelet activation, signaling and aggregation",6/28,263/11009,4.250547575099769e-05,0.00039027755007734247,0.0002399830688333841,CLEC3B/ECM1/F13A1/HRG/PLG/SELENOP,6,,
5,R-HSA-196854,R-HSA-196854,Metabolism of vitamins and cofactors,5/28,194/11009,0.00011405618509346237,0.0009599728912033082,0.0005902907825012525,APOA2/APOA4/BTD/RBP4/TTR,5,,
5,R-HSA-2187338,R-HSA-2187338,Visual phototransduction,4/28,104/11009,0.00012924688018697928,0.001004148838375762,0.0006174547312576338,APOA2/APOA4/RBP4/TTR,4,,
5,R-HSA-8963888,R-HSA-8963888,Chylomicron assembly,2/28,10/11009,0.00027720746619460036,0.0018665302723769757,0.0011477361758232575,APOA2/APOA4,2,,
5,R-HSA-8963901,R-HSA-8963901,Chylomicron remodeling,2/28,10/11009,0.00027720746619460036,0.0018665302723769757,0.0011477361758232575,APOA2/APOA4,2,,
5,R-HSA-75205,R-HSA-75205,Dissolution of Fibrin Clot,2/28,13/11009,0.000478229175592995,0.002961196043902858,0.0018208500947396416,HRG/PLG,2,,
5,R-HSA-2453864,R-HSA-2453864,Retinoid cycle disease events,2/28,14/11009,0.0005570566815262802,0.002961196043902858,0.0018208500947396416,RBP4/TTR,2,,
5,R-HSA-2474795,R-HSA-2474795,Diseases associated with visual transduction,2/28,14/11009,0.0005570566815262802,0.002961196043902858,0.0018208500947396416,RBP4/TTR,2,,
5,R-HSA-9675143,R-HSA-9675143,Diseases of the neuronal system,2/28,14/11009,0.0005570566815262802,0.002961196043902858,0.0018208500947396416,RBP4/TTR,2,,
5,R-HSA-1474244,R-HSA-1474244,Extracellular matrix organization,5/28,300/11009,0.0008530926250666022,0.004308117756586341,0.0026490770988910274,KLKB1/LUM/NCAM1/PLG/TTR,5,,
5,R-HSA-8963898,R-HSA-8963898,Plasma lipoprotein assembly,2/28,19/11009,0.0010385755581462943,0.004995053874894082,0.0030714765880015715,APOA2/APOA4,2,,
5,R-HSA-2453902,R-HSA-2453902,The canonical retinoid cycle in rods (twilight vision),2/28,23/11009,0.0015269728522964818,0.007010193549179302,0.004310593219401551,RBP4/TTR,2,,
5,R-HSA-8957275,R-HSA-8957275,Post-translational protein phosphorylation,3/28,108/11009,0.00251626305931884,0.011049676912660993,0.006794486064064602,APOA2/IGFBP3/SERPINC1,3,,
5,R-HSA-1592389,R-HSA-1592389,Activation of Matrix Metalloproteinases,2/28,33/11009,0.0031370616060188657,0.013201800925329393,0.008117834857680398,KLKB1/PLG,2,,
5,R-HSA-8963899,R-HSA-8963899,Plasma lipoprotein remodeling,2/28,34/11009,0.00332790038060712,0.013444717537652764,0.008267205156034529,APOA2/APOA4,2,,
5,GO:0007596,GO:0007596,blood coagulation,9/34,224/18870,1.6154249641603404e-10,5.245312632866743e-08,3.74053120491385e-08,F10/F12/F13A1/F13B/HGFAC/HRG/KLKB1/PLG/SERPINC1,9,,
5,GO:0050817,GO:0050817,coagulation,9/34,229/18870,1.9657346542781815e-10,5.245312632866743e-08,3.74053120491385e-08,F10/F12/F13A1/F13B/HGFAC/HRG/KLKB1/PLG/SERPINC1,9,,
5,GO:0007599,GO:0007599,hemostasis,9/34,231/18870,2.1236083533873455e-10,5.245312632866743e-08,3.74053120491385e-08,F10/F12/F13A1/F13B/HGFAC/HRG/KLKB1/PLG/SERPINC1,9,,
5,GO:0050878,GO:0050878,regulation of body fluid levels,9/34,365/18870,1.1759051464572304e-08,2.1783642838120195e-06,1.5534325882145518e-06,F10/F12/F13A1/F13B/HGFAC/HRG/KLKB1/PLG/SERPINC1,9,,
5,GO:0051917,GO:0051917,regulation of fibrinolysis,4/34,18/18870,2.6395948849597293e-08,3.911879619510318e-06,2.7896350152627035e-06,F12/HRG/KLKB1/PLG,4,,
5,GO:0072376,GO:0072376,protein activation cascade,4/34,19/18870,3.339234044669361e-08,4.123954045166661e-06,2.940869281445648e-06,F12/F13A1/F13B/KLKB1,4,,
5,GO:0042060,GO:0042060,wound healing,9/34,423/18870,4.190602673459081e-08,4.436052258618828e-06,3.163432394099938e-06,F10/F12/F13A1/F13B/HGFAC/HRG/KLKB1/PLG/SERPINC1,9,,
5,GO:0030193,GO:0030193,regulation of blood coagulation,5/34,68/18870,1.3426250276576118e-07,1.1521598930754645e-05,8.216269143034068e-06,F12/HRG/KLKB1/PLG/SERPINC1,5,,
5,GO:0042730,GO:0042730,fibrinolysis,4/34,27/18870,1.4966433247349488e-07,1.1521598930754645e-05,8.216269143034068e-06,F12/HRG/KLKB1/PLG,4,,
5,GO:1900046,GO:1900046,regulation of hemostasis,5/34,70/18870,1.5548716505741762e-07,1.1521598930754645e-05,8.216269143034068e-06,F12/HRG/KLKB1/PLG/SERPINC1,5,,
5,GO:0050818,GO:0050818,regulation of coagulation,5/34,73/18870,1.922248703664499e-07,1.294896626741267e-05,9.234151667364387e-06,F12/HRG/KLKB1/PLG/SERPINC1,5,,
5,GO:0030195,GO:0030195,negative regulation of blood coagulation,4/34,48/18870,1.6155987499870217e-06,9.976322281169859e-05,7.11430326748671e-05,F12/HRG/KLKB1/PLG,4,,
5,GO:1900047,GO:1900047,negative regulation of hemostasis,4/34,49/18870,1.7569705132319879e-06,0.0001001473192542233,7.141693908036097e-05,F12/HRG/KLKB1/PLG,4,,
5,GO:0050819,GO:0050819,negative regulation of coagulation,4/34,52/18870,2.236419639696971e-06,0.00011837049664396111,8.4412230009615e-05,F12/HRG/KLKB1/PLG,4,,
5,GO:0072378,GO:0072378,"blood coagulation, fibrin clot formation",3/34,16/18870,2.945263659063445e-06,0.00014549602475773417,0.00010375595486665608,F12/F13A1/F13B,3,,
5,GO:0031638,GO:0031638,zymogen activation,4/34,59/18870,3.726392862016896e-06,0.00016600438056286264,0.00011838084955260607,CLEC3B/F12/HGFAC/KLKB1,4,,
5,GO:0061041,GO:0061041,regulation of wound healing,5/34,133/18870,3.8084675702681036e-06,0.00016600438056286264,0.00011838084955260607,F12/HRG/KLKB1/PLG/SERPINC1,5,,
5,GO:0061045,GO:0061045,negative regulation of wound healing,4/34,75/18870,9.751111457280842e-06,0.00040142075499139464,0.000286260698921344,F12/HRG/KLKB1/PLG,4,,
5,GO:0010954,GO:0010954,positive regulation of protein processing,3/34,25/18870,1.1963207625218173e-05,0.00046656509738350876,0.0003327163561141009,CLEC3B/F12/KLKB1,3,,
5,GO:1903034,GO:1903034,regulation of response to wounding,5/34,173/18870,1.371302165616409e-05,0.0005080674523608795,0.0003623124669154933,F12/HRG/KLKB1/PLG/SERPINC1,5,,
5,GO:0031639,GO:0031639,plasminogen activation,3/34,27/18870,1.517663935482029e-05,0.0005111768073600834,0.0003645298065129084,CLEC3B/F12/KLKB1,3,,
5,GO:1903319,GO:1903319,positive regulation of protein maturation,3/34,27/18870,1.517663935482029e-05,0.0005111768073600834,0.0003645298065129084,CLEC3B/F12/KLKB1,3,,
5,GO:0030194,GO:0030194,positive regulation of blood coagulation,3/34,28/18870,1.6976909720178638e-05,0.0005241620876105154,0.00037378985436533664,F12/HRG/PLG,3,,
5,GO:1900048,GO:1900048,positive regulation of hemostasis,3/34,28/18870,1.6976909720178638e-05,0.0005241620876105154,0.00037378985436533664,F12/HRG/PLG,3,,
5,GO:0050820,GO:0050820,positive regulation of coagulation,3/34,30/18870,2.0987990072571884e-05,0.0006220840257510307,0.00044361983227078253,F12/HRG/PLG,3,,
5,GO:1903035,GO:1903035,negative regulation of response to wounding,4/34,97/18870,2.7030102335205448e-05,0.0007703579165533553,0.00054935673571956,F12/HRG/KLKB1/PLG,4,,
5,GO:0016485,GO:0016485,protein processing,5/34,245/18870,7.245683577042619e-05,0.0019885376039216964,0.001418063608450446,BCHE/CLEC3B/F12/HGFAC/KLKB1,5,,
5,GO:1904729,GO:1904729,regulation of intestinal lipid absorption,2/34,10/18870,0.00014052559836106384,0.0035906713236395966,0.002560575331297787,APOA2/APOA4,2,,
5,GO:1905918,GO:1905918,regulation of CoA-transferase activity,2/34,10/18870,0.00014052559836106384,0.0035906713236395966,0.002560575331297787,APOA2/APOA4,2,,
5,GO:0090303,GO:0090303,positive regulation of wound healing,3/34,62/18870,0.00018795741883996758,0.004617525994490315,0.0032928447322027672,F12/HRG/PLG,3,,
5,GO:0034370,GO:0034370,triglyceride-rich lipoprotein particle remodeling,2/34,12/18870,0.00020563880947122858,0.004617525994490315,0.0032928447322027672,APOA2/APOA4,2,,
5,GO:0034372,GO:0034372,very-low-density lipoprotein particle remodeling,2/34,12/18870,0.00020563880947122858,0.004617525994490315,0.0032928447322027672,APOA2/APOA4,2,,
5,GO:1904478,GO:1904478,regulation of intestinal absorption,2/34,12/18870,0.00020563880947122858,0.004617525994490315,0.0032928447322027672,APOA2/APOA4,2,,
5,GO:0070613,GO:0070613,regulation of protein processing,3/34,67/18870,0.00023661807069650121,0.005139431653912726,0.0036650254851398373,CLEC3B/F12/KLKB1,3,,
5,GO:0051918,GO:0051918,negative regulation of fibrinolysis,2/34,13/18870,0.00024275318203366452,0.005139431653912726,0.0036650254851398373,HRG/PLG,2,,
5,GO:1903317,GO:1903317,regulation of protein maturation,3/34,71/18870,0.0002809215095550687,0.0056654894947449665,0.004040167236823599,CLEC3B/F12/KLKB1,3,,
5,GO:0033700,GO:0033700,phospholipid efflux,2/34,14/18870,0.0002828921879967122,0.0056654894947449665,0.004040167236823599,APOA2/APOA4,2,,
5,GO:1903036,GO:1903036,positive regulation of response to wounding,3/34,77/18870,0.0003568957082372407,0.006959466310626193,0.0049629264691162,F12/HRG/PLG,3,,
5,GO:0034375,GO:0034375,high-density lipoprotein particle remodeling,2/34,16/18870,0.0003722026207227399,0.007071849793732058,0.005043069247039552,APOA2/APOA4,2,,
5,GO:0010755,GO:0010755,regulation of plasminogen activation,2/34,18/18870,0.00047348740532274865,0.00855741871571114,0.006102456417766876,CLEC3B/F12,2,,
5,GO:0030299,GO:0030299,intestinal cholesterol absorption,2/34,18/18870,0.00047348740532274865,0.00855741871571114,0.006102456417766876,APOA2/APOA4,2,,
5,GO:0043691,GO:0043691,reverse cholesterol transport,2/34,20/18870,0.0005866642486135433,0.01035043352911037,0.007381089042706735,APOA2/APOA4,2,,
5,GO:0044241,GO:0044241,lipid digestion,2/34,22/18870,0.0007116512648171513,0.011984854255216115,0.008546625237756218,APOA2/APOA4,2,,
5,GO:0098856,GO:0098856,intestinal lipid absorption,2/34,22/18870,0.0007116512648171513,0.011984854255216115,0.008546625237756218,APOA2/APOA4,2,,
5,GO:0022600,GO:0022600,digestive system process,3/34,103/18870,0.0008357204956179637,0.013761530827842467,0.009813606755560651,APOA2/APOA4/RBP4,3,,
5,GO:1901890,GO:1901890,positive regulation of cell junction assembly,3/34,106/18870,0.0009083035467943232,0.01463158539509986,0.010434059050131584,ADGRB3/HRG/IL1RAP,3,,
5,GO:0034377,GO:0034377,plasma lipoprotein particle assembly,2/34,27/18870,0.0010752545923062768,0.016599242768728147,0.011837232573196292,APOA2/APOA4,2,,
5,GO:0050996,GO:0050996,positive regulation of lipid catabolic process,2/34,27/18870,0.0010752545923062768,0.016599242768728147,0.011837232573196292,APOA2/APOA4,2,,
5,GO:0055022,GO:0055022,negative regulation of cardiac muscle tissue growth,2/34,28/18870,0.001156660567889821,0.017141709616127147,0.012224075896435581,PI16/RBP4,2,,
5,GO:0061117,GO:0061117,negative regulation of heart growth,2/34,28/18870,0.001156660567889821,0.017141709616127147,0.012224075896435581,PI16/RBP4,2,,
5,GO:0065005,GO:0065005,protein-lipid complex assembly,2/34,30/18870,0.001328077505608665,0.01929618493443178,0.01376047281353044,APOA2/APOA4,2,,
5,GO:0034368,GO:0034368,protein-lipid complex remodeling,2/34,33/18870,0.0016065658001352928,0.022461608639627397,0.016017796060931816,APOA2/APOA4,2,,
5,GO:0034369,GO:0034369,plasma lipoprotein particle remodeling,2/34,33/18870,0.0016065658001352928,0.022461608639627397,0.016017796060931816,APOA2/APOA4,2,,
5,GO:0007586,GO:0007586,digestion,3/34,134/18870,0.0017836590733641452,0.02433647206530186,0.0173547964724505,APOA2/APOA4/RBP4,3,,
5,GO:0034367,GO:0034367,protein-containing complex remodeling,2/34,35/18870,0.0018063508280588424,0.02433647206530186,0.0173547964724505,APOA2/APOA4,2,,
5,GO:0044058,GO:0044058,regulation of digestive system process,2/34,37/18870,0.0020173446979227893,0.02622548107299626,0.018701884364861317,APOA2/APOA4,2,,
5,GO:0046621,GO:0046621,negative regulation of organ growth,2/34,37/18870,0.0020173446979227893,0.02622548107299626,0.018701884364861317,PI16/RBP4,2,,
5,GO:0046461,GO:0046461,neutral lipid catabolic process,2/34,38/18870,0.002127020404508162,0.026713934232890646,0.01905020951049237,APOA2/APOA4,2,,
5,GO:0046464,GO:0046464,acylglycerol catabolic process,2/34,38/18870,0.002127020404508162,0.026713934232890646,0.01905020951049237,APOA2/APOA4,2,,
5,GO:0050892,GO:0050892,intestinal absorption,2/34,41/18870,0.0024726453864069736,0.030537170522126122,0.021776631297829835,APOA2/APOA4,2,,
5,GO:0002673,GO:0002673,regulation of acute inflammatory response,2/34,49/18870,0.0035143253341524765,0.042690411026344015,0.03044333594037175,F12/KLKB1,2,,
5,GO:0071827,GO:0071827,plasma lipoprotein particle organization,2/34,50/18870,0.003656636524199766,0.043702704265032685,0.031165221309818036,APOA2/APOA4,2,,
5,GO:0035265,GO:0035265,organ growth,3/34,177/18870,0.003921278780763206,0.045724581739487485,0.032607060207717475,ECM1/PI16/RBP4,3,,
5,GO:0051180,GO:0051180,vitamin transport,2/34,52/18870,0.003949221634719567,0.045724581739487485,0.032607060207717475,AFM/GC,2,,
5,GO:0071825,GO:0071825,protein-lipid complex organization,2/34,53/18870,0.0040994766556435,0.046734033874335904,0.03332691953251882,APOA2/APOA4,2,,
5,GO:0120009,GO:0120009,intermembrane lipid transfer,2/34,54/18870,0.004252360760142883,0.04774241398887691,0.034046014379453385,APOA2/APOA4,2,,
6,hsa04610,hsa04610,Complement and coagulation cascades,5/26,88/8843,4.855391423028211e-06,0.000436985228072539,0.0003782094371621975,C4A/C4B/C4BPA/CFB/VWF,5,Organismal Systems,Immune system
6,hsa05133,hsa05133,Pertussis,4/26,78/8843,7.226351654610624e-05,0.003251858244574781,0.0028144738023220322,C4A/C4B/C4BPA/ITGB1,4,Human Diseases,Infectious disease: bacterial
6,R-HSA-977606,R-HSA-977606,Regulation of Complement cascade,4/28,47/11009,5.538332758098788e-06,0.0006965644721340841,0.0005271298708041718,C4A/C4B/C4BPA/CFB,4,,
6,R-HSA-1474244,R-HSA-1474244,Extracellular matrix organization,7/28,300/11009,7.5304267257738825e-06,0.0006965644721340841,0.0005271298708041718,CD44/CTSD/EFEMP1/ITGB1/MMP2/NID1/VWF,7,,
6,R-HSA-166658,R-HSA-166658,Complement cascade,4/28,58/11009,1.2923169907435496e-05,0.0007969288109585221,0.0006030812623469898,C4A/C4B/C4BPA/CFB,4,,
6,R-HSA-166663,R-HSA-166663,Initial triggering of complement,3/28,23/11009,2.5222274981601678e-05,0.0011665302178990775,0.0008827796243560587,C4A/C4B/CFB,3,,
6,R-HSA-449147,R-HSA-449147,Signaling by Interleukins,7/28,473/11009,0.00013936296978313013,0.0046122996041226445,0.0034903888896063266,GSTO1/ITGB1/LBP/LCN2/LCP1/MMP2/YWHAZ,7,,
6,R-HSA-6785807,R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,4/28,108/11009,0.00014958809526884254,0.0046122996041226445,0.0034903888896063266,ITGB1/LBP/LCN2/MMP2,4,,
6,R-HSA-1474228,R-HSA-1474228,Degradation of the extracellular matrix,4/28,140/11009,0.0004046400043145714,0.00937239753405747,0.007092625160908356,CD44/CTSD/MMP2/NID1,4,,
6,R-HSA-430116,R-HSA-430116,GP1b-IX-V activation signalling,2/28,12/11009,0.0004052928663376203,0.00937239753405747,0.007092625160908356,VWF/YWHAZ,2,,
6,R-HSA-75892,R-HSA-75892,Platelet Adhesion to exposed collagen,2/28,15/11009,0.0006417470986819874,0.013191468139574187,0.009982732646164248,ITGB1/VWF,2,,
6,R-HSA-216083,R-HSA-216083,Integrin cell surface interactions,3/28,85/11009,0.001265842989689865,0.023418095309262504,0.017721801855658113,CD44/ITGB1/VWF,3,,
6,R-HSA-3000157,R-HSA-3000157,Laminin interactions,2/28,30/11009,0.002596712885534852,0.04367198943854069,0.0330490730886254,ITGB1/NID1,2,,
6,GO:0006909,GO:0006909,phagocytosis,6/33,237/18870,3.072083979651589e-06,0.0015429760906073811,0.0012148848630174815,C4A/C4B/C4BPA/ITGB1/LBP/SPG11,6,,
6,GO:0008228,GO:0008228,opsonization,3/33,17/18870,3.2586251586401265e-06,0.0015429760906073811,0.0012148848630174815,C4B/C4BPA/LBP,3,,
6,GO:0006959,GO:0006959,humoral immune response,6/33,258/18870,5.008216531449685e-06,0.0015429760906073811,0.0012148848630174815,C4A/C4B/C4BPA/CFB/GAPDH/KRT6A,6,,
6,GO:0006956,GO:0006956,complement activation,4/33,67/18870,5.495907713650512e-06,0.0015429760906073811,0.0012148848630174815,C4A/C4B/C4BPA/CFB,4,,
6,GO:0006910,GO:0006910,"phagocytosis, recognition",3/33,29/18870,1.726155133014122e-05,0.0038769444287497174,0.003052569077330237,C4B/C4BPA/LBP,3,,
6,GO:0006958,GO:0006958,"complement activation, classical pathway",3/33,42/18870,5.339791682105221e-05,0.009994310098340271,0.00786916668941822,C4A/C4B/C4BPA,3,,
6,GO:0010951,GO:0010951,negative regulation of endopeptidase activity,4/33,128/18870,7.096570060224305e-05,0.011212782119808133,0.008828548512573307,CD44/GAPDH/SERPINA11/SERPINA6,4,,
6,GO:0043277,GO:0043277,apoptotic cell clearance,3/33,48/18870,7.987734368518706e-05,0.011212782119808133,0.008828548512573307,C4A/C4B/SPG11,3,,
6,GO:0010466,GO:0010466,negative regulation of peptidase activity,4/33,137/18870,9.239490168044247e-05,0.011528830509681875,0.00907739384930663,CD44/GAPDH/SERPINA11/SERPINA6,4,,
6,GO:0002455,GO:0002455,humoral immune response mediated by circulating immunoglobulin,3/33,55/18870,0.00012015393989748726,0.012515188199568334,0.009854017047979944,C4A/C4B/C4BPA,3,,
6,GO:2000425,GO:2000425,regulation of apoptotic cell clearance,2/33,10/18870,0.0001322967874458991,0.012515188199568334,0.009854017047979944,C4A/C4B,2,,
6,GO:0052548,GO:0052548,regulation of endopeptidase activity,5/33,288/18870,0.00013373308850829922,0.012515188199568334,0.009854017047979944,CD44/CTSD/GAPDH/SERPINA11/SERPINA6,5,,
6,GO:2000392,GO:2000392,regulation of lamellipodium morphogenesis,2/33,11/18870,0.00016151910132999672,0.013952765445660487,0.010985914584388443,CD44/ENPP2,2,,
6,GO:0052547,GO:0052547,regulation of peptidase activity,5/33,312/18870,0.00019421856905010501,0.015579103788804852,0.012266435940006634,CD44/CTSD/GAPDH/SERPINA11/SERPINA6,5,,
6,GO:0032490,GO:0032490,detection of molecule of bacterial origin,2/33,13/18870,0.00022856239252449793,0.01711170445366741,0.013473151559338826,C4B/LBP,2,,
6,GO:0031589,GO:0031589,cell-substrate adhesion,5/33,356/18870,0.0003571031098849106,0.02506417452504716,0.019734645546271374,CD44/ITGB1/NID1/VWF/ZYX,5,,
6,GO:0016064,GO:0016064,immunoglobulin mediated immune response,4/33,205/18870,0.00043241130726243886,0.026998918831165248,0.021257994861675785,C4A/C4B/C4BPA/TFRC,4,,
6,GO:0072673,GO:0072673,lamellipodium morphogenesis,2/33,18/18870,0.00044588703470376954,0.026998918831165248,0.021257994861675785,CD44/ENPP2,2,,
6,GO:0019724,GO:0019724,B cell mediated immunity,4/33,208/18870,0.0004567938181586284,0.026998918831165248,0.021257994861675785,C4A/C4B/C4BPA/TFRC,4,,
6,GO:0097581,GO:0097581,lamellipodium organization,3/33,91/18870,0.0005330563836584247,0.029154186599838674,0.022954976560776573,CD44/ENPP2/ITGB1,3,,
6,GO:0051346,GO:0051346,negative regulation of hydrolase activity,4/33,218/18870,0.0005451806933184436,0.029154186599838674,0.022954976560776573,CD44/GAPDH/SERPINA11/SERPINA6,4,,
6,GO:0045861,GO:0045861,negative regulation of proteolysis,4/33,235/18870,0.0007224275377269956,0.036876642039428004,0.02903536515266394,CD44/GAPDH/SERPINA11/SERPINA6,4,,
6,GO:0007160,GO:0007160,cell-matrix adhesion,4/33,239/18870,0.0007694300087450093,0.037568256513941106,0.02957991795632988,CD44/ITGB1/NID1/ZYX,4,,
6,GO:0008211,GO:0008211,glucocorticoid metabolic process,2/33,25/18870,0.0008676192344325515,0.03953048128267681,0.031124904417161287,H6PD/SERPINA6,2,,
6,GO:0060343,GO:0060343,trabecula formation,2/33,26/18870,0.0009388936333755515,0.03953048128267681,0.031124904417161287,ADGRG6/MMP2,2,,
6,GO:0098581,GO:0098581,detection of external biotic stimulus,2/33,26/18870,0.0009388936333755515,0.03953048128267681,0.031124904417161287,C4B/LBP,2,,
6,GO:0007229,GO:0007229,integrin-mediated signaling pathway,3/33,111/18870,0.0009504211884526036,0.03953048128267681,0.031124904417161287,ITGB1/NID1/ZYX,3,,
7,HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,5/15,200/4383,0.00038850413379800205,0.004662049605576025,0.0036805654780863355,C2/CP/S100A9/SERPING1/TIMP1,5,,
7,HALLMARK_INTERFERON_GAMMA_RESPONSE,HALLMARK_INTERFERON_GAMMA_RESPONSE,HALLMARK_INTERFERON_GAMMA_RESPONSE,5/15,200/4383,0.00038850413379800205,0.004662049605576025,0.0036805654780863355,HLA-A/ICAM1/LGALS3BP/SERPING1/SOD2,5,,
7,HALLMARK_COAGULATION,HALLMARK_COAGULATION,HALLMARK_COAGULATION,4/15,138/4383,0.0009800192099689564,0.007840153679751652,0.006189595010330251,C2/CFI/SERPING1/TIMP1,4,,
7,HALLMARK_ALLOGRAFT_REJECTION,HALLMARK_ALLOGRAFT_REJECTION,HALLMARK_ALLOGRAFT_REJECTION,4/15,200/4383,0.0038610024097927094,0.023166014458756257,0.018288958783228625,C2/HLA-A/ICAM1/TIMP1,4,,
7,HALLMARK_ANGIOGENESIS,HALLMARK_ANGIOGENESIS,HALLMARK_ANGIOGENESIS,2/15,36/4383,0.006440426769151965,0.03091404849192943,0.024405827756786395,NRP1/TIMP1,2,,
7,hsa04610,hsa04610,Complement and coagulation cascades,4/15,88/8843,1.1495587565312433e-05,0.0004965955386641085,0.00040210165074016887,C2/CFHR5/CFI/SERPING1,4,Organismal Systems,Immune system
7,hsa05150,hsa05150,Staphylococcus aureus infection,4/15,100/8843,1.9099828410158018e-05,0.0004965955386641085,0.00040210165074016887,C2/CFI/ICAM1/KRT10,4,Human Diseases,Infectious disease: bacterial
7,R-HSA-166658,R-HSA-166658,Complement cascade,5/21,58/11009,6.493927452283061e-08,7.662834393694012e-06,4.579927782136475e-06,C2/CFHR5/CFI/CRP/SERPING1,5,,
7,R-HSA-977606,R-HSA-977606,Regulation of Complement cascade,4/21,47/11009,1.6547265647714448e-06,9.762886732151525e-05,5.8350884126150955e-05,C2/CFHR5/CFI/SERPING1,4,,
7,R-HSA-1236975,R-HSA-1236975,Antigen processing-Cross presentation,4/21,105/11009,4.127294584069568e-05,0.001623402536400697,0.0009702762706409161,HLA-A/MRC1/S100A8/S100A9,4,,
7,R-HSA-114608,R-HSA-114608,Platelet degranulation,4/21,129/11009,9.226932838145578e-05,0.0025240860668624973,0.0015085973816216533,LGALS3BP/SERPINA3/SERPING1/TIMP1,4,,
7,R-HSA-76005,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,4/21,134/11009,0.00010695279944332616,0.0025240860668624973,0.0015085973816216533,LGALS3BP/SERPINA3/SERPING1/TIMP1,4,,
7,R-HSA-5602498,R-HSA-5602498,MyD88 deficiency (TLR2/4),2/21,17/11009,0.0004632707854668937,0.008775500808134544,0.005244946959366765,S100A8/S100A9,2,,
7,R-HSA-5603041,R-HSA-5603041,IRAK4 deficiency (TLR2/4),2/21,18/11009,0.000520580556414761,0.008775500808134544,0.005244946959366765,S100A8/S100A9,2,,
7,R-HSA-1236974,R-HSA-1236974,ER-Phagosome pathway,3/21,90/11009,0.0006316671941824413,0.00906358157830511,0.005417127259111886,HLA-A/S100A8/S100A9,3,,
7,R-HSA-5686938,R-HSA-5686938,Regulation of TLR by endogenous ligand,2/21,21/11009,0.0007120615894137851,0.00906358157830511,0.005417127259111886,S100A8/S100A9,2,,
7,R-HSA-166663,R-HSA-166663,Initial triggering of complement,2/21,23/11009,0.0008558943252420041,0.00906358157830511,0.005417127259111886,C2/CRP,2,,
7,R-HSA-5668599,R-HSA-5668599,RHO GTPases Activate NADPH Oxidases,2/21,24/11009,0.000932630139704364,0.00906358157830511,0.005417127259111886,S100A8/S100A9,2,,
7,R-HSA-6785807,R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,3/21,108/11009,0.0010737475286553286,0.00906358157830511,0.005417127259111886,ICAM1/SAA1/TIMP1,3,,
7,R-HSA-9635486,R-HSA-9635486,Infection with Mycobacterium tuberculosis,2/21,27/11009,0.001181979458363374,0.00906358157830511,0.005417127259111886,ENO1/MRC1,2,,
7,R-HSA-166058,R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,3/21,113/11009,0.0012239010695817194,0.00906358157830511,0.005417127259111886,S100A8/S100A9/SAA1,3,,
7,R-HSA-168188,R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,3/21,113/11009,0.0012239010695817194,0.00906358157830511,0.005417127259111886,S100A8/S100A9/SAA1,3,,
7,R-HSA-168179,R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,3/21,116/11009,0.0013200503387767646,0.00906358157830511,0.005417127259111886,S100A8/S100A9/SAA1,3,,
7,R-HSA-181438,R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,3/21,116/11009,0.0013200503387767646,0.00906358157830511,0.005417127259111886,S100A8/S100A9/SAA1,3,,
7,R-HSA-76002,R-HSA-76002,"Platelet activation, signaling and aggregation",4/21,263/11009,0.0013825802407584067,0.00906358157830511,0.005417127259111886,LGALS3BP/SERPINA3/SERPING1/TIMP1,4,,
7,R-HSA-5260271,R-HSA-5260271,Diseases of Immune System,2/21,31/11009,0.0015586893694912861,0.00919626727999859,0.005496430934521904,S100A8/S100A9,2,,
7,R-HSA-5602358,R-HSA-5602358,Diseases associated with the TLR signaling cascade,2/21,31/11009,0.0015586893694912861,0.00919626727999859,0.005496430934521904,S100A8/S100A9,2,,
7,R-HSA-381426,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),3/21,125/11009,0.0016367255188860228,0.009196838629930985,0.005496772419316467,CP/IGFBP2/TIMP1,3,,
7,R-HSA-166016,R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,3/21,146/11009,0.002550623610057749,0.013680617544855197,0.00817664028104637,S100A8/S100A9/SAA1,3,,
7,R-HSA-6783783,R-HSA-6783783,Interleukin-10 signaling,2/21,47/11009,0.0035575728690155984,0.018251895588862633,0.010908804678446002,ICAM1/TIMP1,2,,
7,R-HSA-168898,R-HSA-168898,Toll-like Receptor Cascades,3/21,168/11009,0.0037930844500535417,0.018649331879429916,0.011146344655859092,S100A8/S100A9/SAA1,3,,
7,R-HSA-983169,R-HSA-983169,Class I MHC mediated antigen processing & presentation,4/21,381/11009,0.005295165130293448,0.024993179414985075,0.014937939525459413,HLA-A/MRC1/S100A8/S100A9,4,,
7,R-HSA-9824439,R-HSA-9824439,Bacterial Infection Pathways,2/21,73/11009,0.00839479401009702,0.038099449738132625,0.022771303590141713,ENO1/MRC1,2,,
7,R-HSA-449147,R-HSA-449147,Signaling by Interleukins,4/21,473/11009,0.011250143751981941,0.04916729491606922,0.029386340404787138,ICAM1/SAA1/SOD2/TIMP1,4,,
7,R-HSA-6798695,R-HSA-6798695,Neutrophil degranulation,4/21,480/11009,0.011829527364778636,0.04985300818013854,0.029796177948878524,LRG1/S100A8/S100A9/SERPINA3,4,,
7,GO:0007159,GO:0007159,leukocyte cell-cell adhesion,7/22,419/18870,3.2364338601770575e-07,0.0001731924935377884,0.00010273704181944994,FGL1/HLA-A/ICAM1/IGFBP2/LRG1/S100A8/S100A9,7,,
7,GO:0006959,GO:0006959,humoral immune response,6/22,258/18870,3.8274584207246056e-07,0.0001731924935377884,0.00010273704181944994,C2/CFHR5/CFI/HLA-A/S100A9/SERPING1,6,,
7,GO:0006956,GO:0006956,complement activation,4/22,67/18870,1.0117596103250116e-06,0.00030521414911471184,0.0001810517197423705,C2/CFHR5/CFI/SERPING1,4,,
7,GO:2001233,GO:2001233,regulation of apoptotic signaling pathway,6/22,398/18870,4.75136556748702e-06,0.0010749964596439383,0.0006376832735311527,ENO1/ICAM1/NRP1/S100A8/S100A9/SOD2,6,,
7,GO:0006958,GO:0006958,"complement activation, classical pathway",3/22,42/18870,1.5331043040077524e-05,0.002567741288450888,0.0015231730818376886,C2/CFI/SERPING1,3,,
7,GO:0052548,GO:0052548,regulation of endopeptidase activity,5/22,288/18870,1.7023699149950637e-05,0.002567741288450888,0.0015231730818376886,S100A8/S100A9/SERPINA3/SERPING1/TIMP1,5,,
7,GO:0006953,GO:0006953,acute-phase response,3/22,48/18870,2.2993618699021223e-05,0.002829507536553916,0.0016784516936812993,CRP/SAA1/SERPINA3,3,,
7,GO:0052547,GO:0052547,regulation of peptidase activity,5/22,312/18870,2.501222131760368e-05,0.002829507536553916,0.0016784516936812993,S100A8/S100A9/SERPINA3/SERPING1/TIMP1,5,,
7,GO:0002455,GO:0002455,humoral immune response mediated by circulating immunoglobulin,3/22,55/18870,3.469338319104015e-05,0.0034886124208768155,0.0020694298745532725,C2/CFI/SERPING1,3,,
7,GO:0032496,GO:0032496,response to lipopolysaccharide,5/22,348/18870,4.2159446648724056e-05,0.0038154299217095272,0.0022632966095630807,C2/MRC1/S100A8/S100A9/SOD2,5,,
7,GO:0002449,GO:0002449,lymphocyte mediated immunity,5/22,368/18870,5.499754544807861e-05,0.004139710435789674,0.0024556584149493855,C2/CFI/HLA-A/ICAM1/SERPING1,5,,
7,GO:0002237,GO:0002237,response to molecule of bacterial origin,5/22,369/18870,5.5710786600062735e-05,0.004139710435789674,0.0024556584149493855,C2/MRC1/S100A8/S100A9/SOD2,5,,
7,GO:2001242,GO:2001242,regulation of intrinsic apoptotic signaling pathway,4/22,190/18870,6.320218463151001e-05,0.004139710435789674,0.0024556584149493855,ENO1/S100A8/S100A9/SOD2,4,,
7,GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,5/22,380/18870,6.403971944868005e-05,0.004139710435789674,0.0024556584149493855,C2/CFI/HLA-A/ICAM1/SERPING1,5,,
7,GO:0051238,GO:0051238,sequestering of metal ion,2/22,12/18870,8.50346077885396e-05,0.005130421336575223,0.0030433438576951016,S100A8/S100A9,2,,
7,GO:0070486,GO:0070486,leukocyte aggregation,2/22,13/18870,0.0001004244637087886,0.005655177649485989,0.003354627044184768,S100A8/S100A9,2,,
7,GO:0042060,GO:0042060,wound healing,5/22,423/18870,0.00010622985639918433,0.005655177649485989,0.003354627044184768,FGL1/LRG1/SAA1/SERPING1/TIMP1,5,,
7,GO:0017014,GO:0017014,protein nitrosylation,2/22,16/18870,0.0001541720609396692,0.0072058784205614925,0.004274496068027172,S100A8/S100A9,2,,
7,GO:0018119,GO:0018119,peptidyl-cysteine S-nitrosylation,2/22,16/18870,0.0001541720609396692,0.0072058784205614925,0.004274496068027172,S100A8/S100A9,2,,
7,GO:2001234,GO:2001234,negative regulation of apoptotic signaling pathway,4/22,243/18870,0.00016351178622330442,0.0072058784205614925,0.004274496068027172,ENO1/ICAM1/NRP1/SOD2,4,,
7,GO:0002443,GO:0002443,leukocyte mediated immunity,5/22,466/18870,0.00016720822854341584,0.0072058784205614925,0.004274496068027172,C2/CFI/HLA-A/ICAM1/SERPING1,5,,
7,GO:0002523,GO:0002523,leukocyte migration involved in inflammatory response,2/22,19/18870,0.00021923010468763017,0.008626228032274145,0.005117041345111734,S100A8/S100A9,2,,
7,GO:0002544,GO:0002544,chronic inflammatory response,2/22,19/18870,0.00021923010468763017,0.008626228032274145,0.005117041345111734,S100A8/S100A9,2,,
7,GO:0002526,GO:0002526,acute inflammatory response,3/22,107/18870,0.00025237210116427905,0.009135870062146903,0.005419358803948729,CRP/SAA1/SERPINA3,3,,
7,GO:0030593,GO:0030593,neutrophil chemotaxis,3/22,107/18870,0.00025237210116427905,0.009135870062146903,0.005419358803948729,S100A8/S100A9/SAA1,3,,
7,GO:0010951,GO:0010951,negative regulation of endopeptidase activity,3/22,128/18870,0.00042723090042097233,0.014362316986624275,0.008519664627133912,SERPINA3/SERPING1/TIMP1,3,,
7,GO:1990266,GO:1990266,neutrophil migration,3/22,129/18870,0.0004370730700481331,0.014362316986624275,0.008519664627133912,S100A8/S100A9/SAA1,3,,
7,GO:0071621,GO:0071621,granulocyte chemotaxis,3/22,130/18870,0.00044706009914766376,0.014362316986624275,0.008519664627133912,S100A8/S100A9/SAA1,3,,
7,GO:0097193,GO:0097193,intrinsic apoptotic signaling pathway,4/22,319/18870,0.0004608749447676438,0.014362316986624275,0.008519664627133912,ENO1/S100A8/S100A9/SOD2,4,,
7,GO:0044403,GO:0044403,biological process involved in symbiotic interaction,4/22,322/18870,0.0004774437704290539,0.014362316986624275,0.008519664627133912,CFHR5/ICAM1/MRC1/NRP1,4,,
7,GO:0060326,GO:0060326,cell chemotaxis,4/22,325/18870,0.0004944348993675045,0.014362316986624275,0.008519664627133912,NRP1/S100A8/S100A9/SAA1,4,,
7,GO:0010466,GO:0010466,negative regulation of peptidase activity,3/22,137/18870,0.0005211009022769589,0.014362316986624275,0.008519664627133912,SERPINA3/SERPING1/TIMP1,3,,
7,GO:0042742,GO:0042742,defense response to bacterium,4/22,330/18870,0.0005237087961973493,0.014362316986624275,0.008519664627133912,CRP/HLA-A/S100A8/S100A9,4,,
7,GO:0007584,GO:0007584,response to nutrient,3/22,155/18870,0.0007464033161564556,0.01911723695788447,0.011340262690923034,C2/IGFBP2/SOD2,3,,
7,GO:0046718,GO:0046718,viral entry into host cell,3/22,156/18870,0.00076046467456778,0.01911723695788447,0.011340262690923034,ICAM1/MRC1/NRP1,3,,
7,GO:0097530,GO:0097530,granulocyte migration,3/22,156/18870,0.00076046467456778,0.01911723695788447,0.011340262690923034,S100A8/S100A9/SAA1,3,,
7,GO:0006882,GO:0006882,intracellular zinc ion homeostasis,2/22,36/18870,0.0007980532597849179,0.019519951354198668,0.011579151137704356,S100A8/S100A9,2,,
7,GO:0030307,GO:0030307,positive regulation of cell growth,3/22,163/18870,0.0008636481310695485,0.02004106560558824,0.011888273868973544,NRP1/S100A8/S100A9,3,,
7,GO:0044409,GO:0044409,entry into host,3/22,163/18870,0.0008636481310695485,0.02004106560558824,0.011888273868973544,ICAM1/MRC1/NRP1,3,,
7,GO:0042554,GO:0042554,superoxide anion generation,2/22,41/18870,0.0010350774575475477,0.02285774256241126,0.013559114517975857,CRP/SOD2,2,,
7,GO:0050900,GO:0050900,leukocyte migration,4/22,396/18870,0.0010355441381865874,0.02285774256241126,0.013559114517975857,ICAM1/S100A8/S100A9/SAA1,4,,
7,GO:0014002,GO:0014002,astrocyte development,2/22,43/18870,0.0011382402100177005,0.024526366430143307,0.01454893501526384,S100A8/S100A9,2,,
7,GO:0018198,GO:0018198,peptidyl-cysteine modification,2/22,45/18870,0.0012461450717771575,0.025790980721733036,0.01529909877067037,S100A8/S100A9,2,,
7,GO:0001558,GO:0001558,regulation of cell growth,4/22,417/18870,0.001253926134537297,0.025790980721733036,0.01529909877067037,ENO1/NRP1/S100A8/S100A9,4,,
7,GO:0044000,GO:0044000,movement in host,3/22,188/18870,0.0013035581318874025,0.026216002430179984,0.015551219819007608,ICAM1/MRC1/NRP1,3,,
7,GO:0010043,GO:0010043,response to zinc ion,2/22,51/18870,0.0015981063255562252,0.03144100488322574,0.018650668787955946,S100A8/SOD2,2,,
7,GO:0016064,GO:0016064,immunoglobulin mediated immune response,3/22,205/18870,0.001670820951718113,0.032172190666061536,0.0190844050476201,C2/CFI/SERPING1,3,,
7,GO:0019724,GO:0019724,B cell mediated immunity,3/22,208/18870,0.001741679501476569,0.03283791560075615,0.01947931021388268,C2/CFI/SERPING1,3,,
7,GO:0051701,GO:0051701,biological process involved in interaction with host,3/22,211/18870,0.0018143994374123233,0.033510846752207196,0.019878490076912673,ICAM1/MRC1/NRP1,3,,
7,GO:0006935,GO:0006935,chemotaxis,4/22,468/18870,0.0019160487105289502,0.033870158231814496,0.020091632100291235,NRP1/S100A8/S100A9/SAA1,4,,
7,GO:0050832,GO:0050832,defense response to fungus,2/22,56/18870,0.0019234682622759928,0.033870158231814496,0.020091632100291235,S100A8/S100A9,2,,
7,GO:0042330,GO:0042330,taxis,4/22,470/18870,0.0019461306387340924,0.033870158231814496,0.020091632100291235,NRP1/S100A8/S100A9/SAA1,4,,
7,GO:0051346,GO:0051346,negative regulation of hydrolase activity,3/22,218/18870,0.0019914184997575413,0.03400441023170896,0.02017126980886487,SERPINA3/SERPING1/TIMP1,3,,
7,GO:0032102,GO:0032102,negative regulation of response to external stimulus,4/22,481/18870,0.0021174977764153308,0.03415918094358921,0.020263079129084614,HLA-A/NRP1/SAA1/SERPING1,4,,
7,GO:0001906,GO:0001906,cell killing,3/22,223/18870,0.0021242489849812615,0.03415918094358921,0.020263079129084614,CFHR5/HLA-A/ICAM1,3,,
7,GO:0045785,GO:0045785,positive regulation of cell adhesion,4/22,482/18870,0.002133579737353925,0.03415918094358921,0.020263079129084614,HLA-A/IGFBP2/NRP1/SAA1,4,,
7,GO:0007596,GO:0007596,blood coagulation,3/22,224/18870,0.002151462225176337,0.03415918094358921,0.020263079129084614,FGL1/SAA1/SERPING1,3,,
7,GO:0050817,GO:0050817,coagulation,3/22,229/18870,0.0022907986509268017,0.0353859013434501,0.020990764390996855,FGL1/SAA1/SERPING1,3,,
7,GO:0007599,GO:0007599,hemostasis,3/22,231/18870,0.0023480708771532886,0.0353859013434501,0.020990764390996855,FGL1/SAA1/SERPING1,3,,
7,GO:0001667,GO:0001667,ameboidal-type cell migration,4/22,497/18870,0.0023851270518789568,0.0353859013434501,0.020990764390996855,LRG1/NRP1/S100A9/TIMP1,4,,
7,GO:0016049,GO:0016049,cell growth,4/22,497/18870,0.0023851270518789568,0.0353859013434501,0.020990764390996855,ENO1/NRP1/S100A8/S100A9,4,,
7,GO:0045861,GO:0045861,negative regulation of proteolysis,3/22,235/18870,0.002465278190568875,0.03596779133287723,0.02133593902851688,SERPINA3/SERPING1/TIMP1,3,,
7,GO:2001244,GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,2/22,64/18870,0.0025038351977583044,0.03596779133287723,0.02133593902851688,S100A8/S100A9,2,,
7,GO:0030595,GO:0030595,leukocyte chemotaxis,3/22,240/18870,0.0026168297315869123,0.03673524289662852,0.021791187993347536,S100A8/S100A9/SAA1,3,,
7,GO:0032944,GO:0032944,regulation of mononuclear cell proliferation,3/22,242/18870,0.002679034288593903,0.03673524289662852,0.021791187993347536,CRP/HLA-A/IGFBP2,3,,
7,GO:0097529,GO:0097529,myeloid leukocyte migration,3/22,242/18870,0.002679034288593903,0.03673524289662852,0.021791187993347536,S100A8/S100A9/SAA1,3,,
7,GO:0009620,GO:0009620,response to fungus,2/22,67/18870,0.002740222324449521,0.03700362278334847,0.02195038978715641,S100A8/S100A9,2,,
7,GO:0006919,GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,2/22,68/18870,0.0028212706873492204,0.03700362278334847,0.02195038978715641,S100A8/S100A9,2,,
7,GO:2000379,GO:2000379,positive regulation of reactive oxygen species metabolic process,2/22,68/18870,0.0028212706873492204,0.03700362278334847,0.02195038978715641,CRP/SOD2,2,,
7,GO:0045927,GO:0045927,positive regulation of growth,3/22,256/18870,0.0031402607660470745,0.040236313999884185,0.023868008304671052,NRP1/S100A8/S100A9,3,,
7,GO:0006801,GO:0006801,superoxide metabolic process,2/22,72/18870,0.003156661098333456,0.040236313999884185,0.023868008304671052,CRP/SOD2,2,,
7,GO:0070663,GO:0070663,regulation of leukocyte proliferation,3/22,267/18870,0.003535008125915518,0.044433088249354775,0.02635751672831746,CRP/HLA-A/IGFBP2,3,,
8,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,4/25,49/4383,0.00014680019690092635,0.004110405513225938,0.0035541100302329534,CAT/PRDX2/SOD1/TXN,4,,
8,HALLMARK_GLYCOLYSIS,HALLMARK_GLYCOLYSIS,HALLMARK_GLYCOLYSIS,6/25,200/4383,0.0007157040151513712,0.0066799041414127985,0.005775856964379487,LDHA/PGK1/PPIA/SOD1/TALDO1/TXN,6,,
8,HALLMARK_HEME_METABOLISM,HALLMARK_HEME_METABOLISM,HALLMARK_HEME_METABOLISM,6/25,200/4383,0.0007157040151513712,0.0066799041414127985,0.005775856964379487,CA1/CA2/CAT/HBB/PRDX2/SELENBP1,6,,
8,hsa00010,hsa00010,Glycolysis / Gluconeogenesis,3/29,67/8843,0.0013194239896568277,0.039475097490228706,0.030220170327447813,LDHA/LDHB/PGK1,3,Metabolism,Carbohydrate metabolism
8,hsa00910,hsa00910,Nitrogen metabolism,2/29,17/8843,0.0013698848067793103,0.039475097490228706,0.030220170327447813,CA1/CA2,2,Metabolism,Energy metabolism
8,hsa00511,hsa00511,Other glycan degradation,2/29,18/8843,0.0015379908113076117,0.039475097490228706,0.030220170327447813,FUCA2/MANBA,2,Metabolism,Glycan biosynthesis and metabolism
8,R-HSA-1237044,R-HSA-1237044,Erythrocytes take up carbon dioxide and release oxygen,4/35,13/11009,5.997146310804026e-08,4.377916806886939e-06,3.187956723111614e-06,CA1/CA2/HBA1/HBB,4,,
8,R-HSA-1480926,R-HSA-1480926,O2/CO2 exchange in erythrocytes,4/35,13/11009,5.997146310804026e-08,4.377916806886939e-06,3.187956723111614e-06,CA1/CA2/HBA1/HBB,4,,
8,R-HSA-9711123,R-HSA-9711123,Cellular response to chemical stress,7/35,215/11009,4.151106422195708e-06,0.00017087600022039416,0.00012443025250367566,CAT/HBA1/HBB/PRDX2/SOD1/TALDO1/TXN,7,,
8,R-HSA-3299685,R-HSA-3299685,Detoxification of Reactive Oxygen Species,4/35,37/11009,5.247744737977712e-06,0.00017087600022039416,0.00012443025250367566,CAT/PRDX2/SOD1/TXN,4,,
8,R-HSA-8950505,R-HSA-8950505,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,4/35,38/11009,5.851917815766924e-06,0.00017087600022039416,0.00012443025250367566,CA1/PPIA/SOD1/TALDO1,4,,
8,R-HSA-6798695,R-HSA-6798695,Neutrophil degranulation,9/35,480/11009,1.3525256638605151e-05,0.0002890057646348139,0.00021045120568216445,CAT/CEACAM8/CST3/FUCA2/HBB/MANBA/PNP/PPIA/PRSS3,9,,
8,R-HSA-9020591,R-HSA-9020591,Interleukin-12 signaling,4/35,47/11009,1.385644077016231e-05,0.0002890057646348139,0.00021045120568216445,CA1/PPIA/SOD1/TALDO1,4,,
8,R-HSA-447115,R-HSA-447115,Interleukin-12 family signaling,4/35,57/11009,3.0002782790091765e-05,0.0005475507859191747,0.00039872119234200907,CA1/PPIA/SOD1/TALDO1,4,,
8,R-HSA-1475029,R-HSA-1475029,Reversible hydration of carbon dioxide,2/35,12/11009,0.0006352617459993096,0.010305357212877687,0.007504261560927517,CA1/CA2,2,,
8,R-HSA-2168880,R-HSA-2168880,Scavenging of heme from plasma,2/35,13/11009,0.0007492660554194945,0.010939284409124618,0.00796588122077568,HBA1/HBB,2,,
8,GO:0042743,GO:0042743,hydrogen peroxide metabolic process,6/40,54/18870,1.4690295998169273e-09,1.6306228557967892e-06,1.271097190578436e-06,CAT/HBA1/HBB/PRDX2/SOD1/TXN,6,,
8,GO:0098869,GO:0098869,cellular oxidant detoxification,6/40,99/18870,5.944734873401663e-08,3.299327854737923e-05,2.5718800347032456e-05,CAT/HBA1/HBB/PRDX2/SOD1/TXN,6,,
8,GO:1990748,GO:1990748,cellular detoxification,6/40,119/18870,1.7848618328369002e-07,6.603988781496531e-05,5.147917286287481e-05,CAT/HBA1/HBB/PRDX2/SOD1/TXN,6,,
8,GO:0097237,GO:0097237,cellular response to toxic substance,6/40,128/18870,2.7510441284311715e-07,7.634147456396501e-05,5.950942825185324e-05,CAT/HBA1/HBB/PRDX2/SOD1/TXN,6,,
8,GO:0042744,GO:0042744,hydrogen peroxide catabolic process,4/40,31/18870,5.224909540276396e-07,0.00011599299179413599,9.041843457067785e-05,CAT/HBA1/HBB/PRDX2,4,,
8,GO:0098754,GO:0098754,detoxification,6/40,158/18870,9.504330865462988e-07,0.00017583012101106527,0.00013706245563878204,CAT/HBA1/HBB/PRDX2/SOD1/TXN,6,,
8,GO:0006979,GO:0006979,response to oxidative stress,8/40,400/18870,1.6142432926229248e-06,0.0002559728649730638,0.00019953503556932996,CAT/HBA1/HBB/MBL2/PPIA/PRDX2/SOD1/TXN,8,,
8,GO:0042542,GO:0042542,response to hydrogen peroxide,5/40,101/18870,2.2544747413091606e-06,0.00031280837035664604,0.00024383924175738555,CAT/HBA1/HBB/SOD1/TXN,5,,
8,GO:0015670,GO:0015670,carbon dioxide transport,3/40,15/18870,3.944613179173918e-06,0.00047846109657035925,0.000372968251665088,CA2/HBA1/HBB,3,,
8,GO:0000302,GO:0000302,response to reactive oxygen species,6/40,205/18870,4.310460329462696e-06,0.00047846109657035925,0.000372968251665088,CAT/HBA1/HBB/PRDX2/SOD1/TXN,6,,
8,GO:0031638,GO:0031638,zymogen activation,4/40,59/18870,7.241364636242049e-06,0.0007307195223844249,0.0005696078211474608,APOH/CTSL/PGK1/PRSS3,4,,
8,GO:0072593,GO:0072593,reactive oxygen species metabolic process,6/40,234/18870,9.19975347664471e-06,0.0008509771965896357,0.0006633506454212239,CAT/HBA1/HBB/PRDX2/SOD1/TXN,6,,
8,GO:0015669,GO:0015669,gas transport,3/40,22/18870,1.3214259689371031e-05,0.0011282944811693727,0.0008795240052358696,CA2/HBA1/HBB,3,,
8,GO:0009636,GO:0009636,response to toxic substance,6/40,258/18870,1.6020090859536714e-05,0.001270164346720411,0.0009901138862059532,CAT/HBA1/HBB/PRDX2/SOD1/TXN,6,,
8,GO:1901136,GO:1901136,carbohydrate derivative catabolic process,5/40,178/18870,3.5550363963126514e-05,0.002630726933271362,0.00205069467913614,CST3/CTSL/FUCA2/MANBA/PNP,5,,
8,GO:0043410,GO:0043410,positive regulation of MAPK cascade,7/40,474/18870,5.4887493411619496e-05,0.0038078198554311027,0.002968257867391528,CSF1R/GLIPR2/GPNMB/IGFBP6/PPIA/PRDX2/SOD1,7,,
8,GO:0006516,GO:0006516,glycoprotein catabolic process,3/40,36/18870,6.001832282540456e-05,0.003918843431541121,0.0030548025611444297,CST3/CTSL/MANBA,3,,
8,GO:0034599,GO:0034599,cellular response to oxidative stress,5/40,255/18870,0.00019372650815097754,0.011946468002643615,0.009312467233924183,CAT/PPIA/PRDX2/SOD1/TXN,5,,
8,GO:0019755,GO:0019755,one-carbon compound transport,3/40,61/18870,0.00029162681812842293,0.017037145690660498,0.013280733767399648,CA2/HBA1/HBB,3,,
8,GO:0034614,GO:0034614,cellular response to reactive oxygen species,4/40,154/18870,0.00031018185175832455,0.017215092772587013,0.013419446428702252,CAT/PRDX2/SOD1/TXN,4,,
8,GO:0015671,GO:0015671,oxygen transport,2/40,15/18870,0.0004520780710677294,0.023895555185008552,0.018626976161286894,HBA1/HBB,2,,
8,GO:0062197,GO:0062197,cellular response to chemical stress,5/40,317/18870,0.0005266352445234569,0.02657114188277442,0.02071263976068333,CAT/PPIA/PRDX2/SOD1/TXN,5,,
8,GO:0044403,GO:0044403,biological process involved in symbiotic interaction,5/40,322/18870,0.0005653926148535364,0.027286339238583715,0.02127014779906668,CSF1R/CTSL/FUCA2/MBL2/PPIA,5,,
8,GO:0006089,GO:0006089,lactate metabolic process,2/40,18/18870,0.0006560972619841112,0.030344498366765144,0.023654032866269274,LDHA/LDHB,2,,
8,GO:0034103,GO:0034103,regulation of tissue remodeling,3/40,85/18870,0.000772663310666629,0.03298677980153685,0.025713734468338828,CSF1R/CST3/GPNMB,3,,
8,GO:0072524,GO:0072524,pyridine-containing compound metabolic process,3/40,85/18870,0.000772663310666629,0.03298677980153685,0.025713734468338828,LDHB/PNP/TALDO1,3,,
8,GO:0061687,GO:0061687,detoxification of inorganic compound,2/40,22/18870,0.0009852808364728919,0.04050598994388556,0.03157508177702601,CAT/TXN,2,,
8,GO:0019430,GO:0019430,removal of superoxide radicals,2/40,23/18870,0.0010776719569621097,0.04272199543671221,0.033302494309129856,PRDX2/SOD1,2,,
8,GO:0007596,GO:0007596,blood coagulation,4/40,224/18870,0.001263663547226289,0.045633611113609855,0.03557214635883101,APOH/HBB/PPIA/PRDX2,4,,
8,GO:0071450,GO:0071450,cellular response to oxygen radical,2/40,25/18870,0.001274452202271987,0.045633611113609855,0.03557214635883101,PRDX2/SOD1,2,,
8,GO:0071451,GO:0071451,cellular response to superoxide,2/40,25/18870,0.001274452202271987,0.045633611113609855,0.03557214635883101,PRDX2/SOD1,2,,
8,GO:0050817,GO:0050817,coagulation,4/40,229/18870,0.001370684797181636,0.046202679085895836,0.03601574415230572,APOH/HBB/PPIA/PRDX2,4,,
8,GO:0032148,GO:0032148,activation of protein kinase B activity,2/40,26/18870,0.0013788083046050044,0.046202679085895836,0.03601574415230572,PPIA/TXN,2,,
8,GO:0007599,GO:0007599,hemostasis,4/40,231/18870,0.0014152171972256382,0.046202679085895836,0.03601574415230572,APOH/HBB/PPIA/PRDX2,4,,
8,GO:0031639,GO:0031639,plasminogen activation,2/40,27/18870,0.0014871197934021644,0.04671844764496325,0.036417794181280036,APOH/PGK1,2,,
8,GO:0000303,GO:0000303,response to superoxide,2/40,28/18870,0.0015993702797374807,0.04671844764496325,0.036417794181280036,PRDX2/SOD1,2,,
8,GO:0030194,GO:0030194,positive regulation of blood coagulation,2/40,28/18870,0.0015993702797374807,0.04671844764496325,0.036417794181280036,APOH/PRDX2,2,,
8,GO:1900048,GO:1900048,positive regulation of hemostasis,2/40,28/18870,0.0015993702797374807,0.04671844764496325,0.036417794181280036,APOH/PRDX2,2,,
8,GO:0000305,GO:0000305,response to oxygen radical,2/40,29/18870,0.0017155434233869712,0.048720908962220935,0.03797874553527322,PRDX2/SOD1,2,,
8,GO:0016485,GO:0016485,protein processing,4/40,245/18870,0.0017557084310710247,0.048720908962220935,0.03797874553527322,APOH/CTSL/PGK1/PRSS3,4,,
8,GO:0050820,GO:0050820,positive regulation of coagulation,2/40,30/18870,0.0018356229327040436,0.049696133056133865,0.03873894866964631,APOH/PRDX2,2,,
